Knowledge

Antiviral drug

Source 📝

924:(Rapivab). Influenza antiviral resistance often results from changes occurring in neuraminidase and hemagglutinin proteins on the viral surface. Currently, neuraminidase inhibitors (NAIs) are the most frequently prescribed antivirals because they are effective against both influenza A and B. However, antiviral resistance is known to develop if mutations to the neuraminidase proteins prevent NAI binding. This was seen in the H257Y mutation, which was responsible for oseltamivir resistance to H1N1 strains in 2009. The inability of NA inhibitors to bind to the virus allowed this strain of virus with the resistance mutation to spread due to natural selection. Furthermore, a study published in 2009 in 47: 949:
less than 30 kb, which allow them to sustain a high frequency of mutations. DNA viruses, such as HPV and herpesvirus, hijack host cell replication machinery, which gives them proofreading capabilities during replication. DNA viruses are therefore less error prone, are generally less diverse, and are more slowly evolving than RNA viruses. In both cases, the likelihood of mutations is exacerbated by the speed with which viruses reproduce, which provides more opportunities for mutations to occur in successive replications. Billions of viruses are produced every day during the course of an infection, with each replication giving another chance for mutations that encode for resistance to occur.
991:
viral life cycle. This is frequently used in retroviruses like HIV, but a number of studies have demonstrated its effectiveness against influenza A, as well. Viruses can also be screened for resistance to drugs before treatment is started. This minimizes exposure to unnecessary antivirals and ensures that an effective medication is being used. This may improve patient outcomes and could help detect new resistance mutations during routine scanning for known mutants. However, this has not been consistently implemented in treatment facilities at this time.
5155: 5176: 351:" strategies for developing antivirals have tried to attack viruses at every stage of their life cycles. Some species of mushrooms have been found to contain multiple antiviral chemicals with similar synergistic effects. Compounds isolated from fruiting bodies and filtrates of various mushrooms have broad-spectrum antiviral activities, but successful production and availability of such compounds as frontline antiviral is a long way away. 193: 1185: 295:
should also be common across many strains of a virus, or even among different species of virus in the same family, so a single drug will have broad effectiveness. For example, a researcher might target a critical enzyme synthesized by the virus, but not by the patient, that is common across strains, and see what can be done to interfere with its operation.
444:, or the brand name Fuzeon—has received FDA approval and has been in use for some time. Potentially, one of the benefits from the use of an effective entry-blocking or entry-inhibiting agent is that it potentially may not only prevent the spread of the virus within an infected individual but also the spread from an infected to an uninfected individual. 1127:(LHDs) with access to antivirals, guidelines may be unclear, causing delays in treatment. With time-sensitive therapies, delays could lead to lack of treatment. Overall, national guidelines, regarding infection control and management, standardize care and improve healthcare worker and patient safety. Guidelines, such as those provided by the 873:, protein molecules that can bind to a pathogen and mark it for attack by other elements of the immune system. Once researchers identify a particular target on the pathogen, they can synthesize quantities of identical "monoclonal" antibodies to link up that target. A monoclonal drug is now being sold to help fight 428:, when the virus attaches to and enters the host cell. A number of "entry-inhibiting" or "entry-blocking" drugs are being developed to fight HIV. HIV most heavily targets a specific type of lymphocyte known as "helper T cells", and identifies these target cells through T-cell surface receptors designated " 990:
The most commonly used method for treating resistant viruses is combination therapy, which uses multiple antivirals in one treatment regimen. This is thought to decrease the likelihood that one mutation could cause antiviral resistance, as the antivirals in the cocktail target different stages of the
986:
If a virus is not fully wiped out during a regimen of antivirals, treatment creates a bottleneck in the viral population that selects for resistance, and there is a chance that a resistant strain may repopulate the host. Viral treatment mechanisms must therefore account for the selection of resistant
939:
The genetic makeup of viruses is constantly changing, which can cause a virus to become resistant to currently available treatments. Viruses can become resistant through spontaneous or intermittent mechanisms throughout the course of an antiviral treatment. Immunocompromised patients, more often than
908:
viruses (depending on the vaccination). Comprehensive protection starts by ensuring vaccinations are current and complete. However, vaccines are preventative and are not generally used once a patient has been infected with a virus. Additionally, the availability of these vaccines can be limited based
447:
One possible advantage of the therapeutic approach of blocking viral entry (as opposed to the currently dominant approach of viral enzyme inhibition) is that it may prove more difficult for the virus to develop resistance to this therapy than for the virus to mutate or evolve its enzymatic protocols.
948:
The mechanisms for antiviral resistance development depend on the type of virus in question. RNA viruses such as hepatitis C and influenza A have high error rates during genome replication because RNA polymerases lack proofreading activity. RNA viruses also have small genome sizes that are typically
888:
can be defined by a decreased susceptibility to a drug caused by changes in viral genotypes. In cases of antiviral resistance, drugs have either diminished or no effectiveness against their target virus. The issue inevitably remains a major obstacle to antiviral therapy as it has developed to almost
698:
has been suggested, and ribozyme antivirals are being developed to deal with HIV. An interesting variation of this idea is the use of genetically modified cells that can produce custom-tailored ribozymes. This is part of a broader effort to create genetically modified cells that can be injected into
521:
can cause them too. Rhinoviruses also exacerbate asthma attacks. Although rhinoviruses come in many varieties, they do not drift to the same degree that influenza viruses do. A mixture of 50 inactivated rhinovirus types should be able to stimulate neutralizing antibodies against all of them to some
167:
drug discovery methods. Researchers grew cultures of cells and infected them with the target virus. They then introduced into the cultures chemicals which they thought might inhibit viral activity and observed whether the level of virus in the cultures rose or fell. Chemicals that seemed to have an
1172:
prepare for shortages of antiviral medications in cases of public health emergencies. During the H1N1 pandemic in 2009–2010, guidelines for SNS use by local health departments was unclear, revealing gaps in antiviral planning. For example, local health departments that received antivirals from the
930:
emphasized the urgent need for augmentation of oseltamivir stockpiles with additional antiviral drugs including zanamivir. This finding was based on a performance evaluation of these drugs supposing the 2009 H1N1 'Swine Flu' neuraminidase (NA) were to acquire the oseltamivir-resistance (His274Tyr)
439:
HIV infects a cell through fusion with the cell membrane, which requires two different cellular molecular participants, CD4 and a chemokine receptor (differing depending on the cell type). Approaches to blocking this virus/cell fusion have shown some promise in preventing entry of the virus into a
151:
The emergence of antivirals is the product of a greatly expanded knowledge of the genetic and molecular function of organisms, allowing biomedical researchers to understand the structure and function of viruses, major advances in the techniques for finding new drugs, and the pressure placed on the
294:
The general idea behind modern antiviral drug design is to identify viral proteins, or parts of proteins, that can be disabled. These "targets" should generally be as unlike any proteins or parts of proteins in humans as possible, to reduce the likelihood of side effects and toxicity. The targets
3762:
Yoshida, Eric M.; Sulkowski, Mark S.; Gane, Edward J.; Herring, Robert W.; Ratziu, Vlad; Ding, Xiao; Wang, Jing; Chuang, Shu‐Min; Ma, Julie; McNally, John; Stamm, Luisa M.; Brainard, Diana M.; Symonds, William T.; McHutchison, John G.; Beavers, Kimberly L.; Jacobson, Ira M.; Reddy, K. Rajender;
1122:
Guidelines regarding viral diagnoses and treatments change frequently and limit quality care. Even when physicians diagnose older patients with influenza, use of antiviral treatment can be low. Provider knowledge of antiviral therapies can improve patient care, especially in geriatric medicine.
631:
Genomics has not only helped find targets for many antivirals, it has provided the basis for an entirely new type of drug, based on "antisense" molecules. These are segments of DNA or RNA that are designed as complementary molecule to critical sections of viral genomes, and the binding of these
3839:
van der Meer, Adriaan J.; Veldt, Bart J.; Feld, Jordan J.; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Heathcote, E. Jenny; Manns, Michael P.; Kuske, Lorenz; Zeuzem, Stefan; Hofmann, W. Peter; de Knegt, Robert J.; Hansen, Bettina E.; Janssen, Harry L. A. (26
977:
further recommends in-depth epidemiological investigations to control potential transmission of the resistant virus and prevent future progression. As novel treatments and detection techniques to antiviral resistance are enhanced so can the establishment of strategies to combat the inevitable
499:
Some scientists are making the case that a vaccine against rhinoviruses, the predominant cause of the common cold, is achievable. Vaccines that combine dozens of varieties of rhinovirus at once are effective in stimulating antiviral antibodies in mice and monkeys, researchers reported in
383:" molecule on the surface of the host cell and ending with the virus "uncoating" inside the cell and releasing its contents. Viruses that have a lipid envelope must also fuse their envelope with the target cell, or with a vesicle that transports them into the cell before they can uncoat. 858:
Rather than attacking viruses directly, a second category of tactics for fighting viruses involves encouraging the body's immune system to attack them. Some antivirals of this sort do not focus on a specific pathogen, instead stimulating the immune system to attack a range of pathogens.
147:
Viruses use the host's cells to replicate and this makes it difficult to find targets for the drug that would interfere with the virus without also harming the host organism's cells. Moreover, the major difficulty in developing vaccines and antiviral drugs is due to viral variation.
723:" to attack HIV at that phase of its life cycle. Protease inhibitors became available in the 1990s and have proven effective, though they can have unusual side effects, for example causing fat to build up in unusual places. Improved protease inhibitors are now in development. 866:, which inhibit viral synthesis in infected cells. One form of human interferon named "interferon alpha" is well-established as part of the standard treatment for hepatitis B and C, and other interferons are also being investigated as treatments for various diseases. 804:
selectively in virus-infected mammalian cells, while leaving uninfected cells unharmed. DRACO effects cell death via one of the last steps in the apoptosis pathway in which complexes containing intracellular apoptosis signalling molecules simultaneously bind multiple
956:, results in immense variation in any given sample of virus, and gives the opportunity for natural selection to favor viral strains with the highest fitness every time the virus is spread to a new host. Recombination, the joining of two different viral variants, and 972:
National and international surveillance is performed by the CDC to determine effectiveness of the current FDA-approved antiviral flu drugs. Public health officials use this information to make current recommendations about the use of flu antiviral medications.
1073:
remains undetectable 12–24 weeks after treatment ends. Whether through DAAs or older interferon-based regimens, SVR is associated with improved health outcomes and significantly decreased mortality. For those who already have advanced liver disease (including
691:, which are enzymes that will cut apart viral RNA or DNA at selected sites. In their natural course, ribozymes are used as part of the viral manufacturing sequence, but these synthetic ribozymes are designed to cut RNA and DNA at sites that will disable them. 436:". Attempts to interfere with the binding of HIV with the CD4 receptor have failed to stop HIV from infecting helper T cells, but research continues on trying to interfere with the binding of HIV to the CCR5 receptor in hopes that it will be more effective. 2620:
Suzuki H, Okubo A, Yamazaki S, Suzuki K, Mitsuya H, Toda S (1989). "Inhibition of the infectivity and cytopathic effect of human immunodeficiency virus by water-soluble lignin in an extract of the culture medium of Lentinus edodes mycelia (LEM)".
576:, has been approved to treat hepatitis B, which uses reverse transcriptase as part of its replication process. Researchers have gone further and developed inhibitors that do not look like nucleosides, but can still block reverse transcriptase. 944:
are at the highest risk of developing oseltamivir resistance during treatment. Subsequent to exposure to someone else with the flu, those who received oseltamivir for "post-exposure prophylaxis" are also at higher risk of resistance.
1623:
Wu, Gaochan; Zhao, Tong; Kang, Dongwei; Zhang, Jian; Song, Yuning; Namasivayam, Vigneshwaran; Kongsted, Jacob; Pannecouque, Christophe; De Clercq, Erik; Poongavanam, Vasanthanathan; Liu, Xinyong; Zhan, Peng (14 November 2019).
3866:
Backus, Lisa I.; Belperio, Pamela S.; Shahoumian, Troy A.; Mole, Larry A. (February 2019). "Impact of Sustained Virologic Response with Direct‐Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease".
963:
Antiviral resistance has been reported in antivirals for herpes, HIV, hepatitis B and C, and influenza, but antiviral resistance is a possibility for all viruses. Mechanisms of antiviral resistance vary between virus types.
409:
This strategy of designing drugs can be very expensive, and since the process of generating anti-idiotypic antibodies is partly trial and error, it can be a relatively slow process until an adequate molecule is produced.
5660: 313:
or other kinds of cells. The cells are then cultured for mass production of the protein, which can then be exposed to various treatment candidates and evaluated with "rapid screening" technologies.
171:
This was a very time-consuming, hit-or-miss procedure, and in the absence of a good knowledge of how the target virus worked, it was not efficient in discovering effective antivirals which had few
344:
layer (sometimes called an 'envelope'). Viruses cannot reproduce on their own and instead propagate by subjugating a host cell to produce copies of themselves, thus producing the next generation.
3980:
Lindegren, Mary Louise; Griffin, Marie R.; Williams, John V.; Edwards, Kathryn M.; Zhu, Yuwei; Mitchel, Ed; Fry, Alicia M.; Schaffner, William; Talbot, H. Keipp; Pyrc, Krzysztof (25 March 2015).
1081:
Despite its historical roots in hepatitis C research, the term "direct-acting antivirals" is becoming more broadly used to also include other anti-viral drugs with a direct viral target such as
1173:
SNS did not have transparent guidance on the use of the treatments. The gap made it difficult to create plans and policies for their use and future availabilities, causing delays in treatment.
379:
One antiviral strategy is to interfere with the ability of a virus to infiltrate a target cell. The virus must go through a sequence of steps to do this, beginning with binding to a specific "
298:
Once targets are identified, candidate drugs can be selected, either from drugs already known to have appropriate effects or by actually designing the candidate at the molecular level with a
6693: 5634: 3139:
Nijhuis, M; van Maarseveen, NM; Boucher, CA (2009). "Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases".
6656: 5552: 3096:
Soundararajan, V; Tharakaraman, K; Raman, R; Raguram, S; Shriver, Z; Sasisekharan, V; Sasisekharan, R (June 2009). "Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus".
1023:) of hepatitis C virus that are causing the infection. Both during and at the end of treatment, blood tests are used to monitor the effectiveness of the treatment and subsequent cure. 832:
The final stage in the life cycle of a virus is the release of completed viruses from the host cell, and this step has also been targeted by antiviral drug developers. Two drugs named
3798:"Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response" 1160:
initiatives are managed by the CDC via the Office of Public Health Preparedness and Response. Funds aim to support communities in preparing for public health emergencies, including
719:
that cuts viral protein chains apart so they can be assembled into their final configuration. HIV includes a protease, and so considerable research has been performed to find "
952:
Multiple strains of one virus can be present in the body at one time, and some of these strains may contain mutations that cause antiviral resistance. This effect, called the
3894:
Kleandrova VV, Scotti MT, Speck-Planche A (2021). "Indirect-Acting Pan-Antivirals vs. Respiratory Viruses: A Fresh Perspective on Computational Multi-Target Drug Discovery".
5654: 179:
of viruses began to be unraveled, did researchers begin to learn how viruses worked in detail, and exactly what chemicals were needed to thwart their reproductive cycle.
5844: 1861:
Pradeep, Prabin; Manju, Vidya; Ahsan, Mohammad Feraz (2019), Agrawal, Dinesh Chandra; Dhanasekaran, Muralikrishnan (eds.), "Antiviral Potency of Mushroom Constituents",
4091: 5849: 7596: 5795: 1169: 1585: 554:, but deactivate the enzymes that synthesize the RNA or DNA once the analogue is incorporated. This approach is more commonly associated with the inhibition of 5267: 1411:
Schnitzler, P; Schön, K; Reichling, J (2001). "Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture".
1209: 104:, which are not medication but deactivate or destroy virus particles, either inside or outside the body. Natural virucides are produced by some plants such as 8480: 6234: 5107: 4187: 5431: 4043: 3180: 2158:
Deas, T. S.; Binduga-Gajewska, I.; Tilgner, M.; Ren, P.; Stein, D. A.; Moulton, H. M.; Iversen, P. L.; Kauffman, E. B.; Kramer, L. D.; Shi, P. -Y. (2005).
2123:
Stein DA, Skilling DE, Iversen PL, Smith AW (2001). "Inhibition of Vesivirus infections in mammalian tissue culture with antisense morpholino oligomers".
2581:"The inhibitory properties and primary structure of a novel serine proteinase inhibitor from the fruiting body of the basidiomycete, Lentinus edodes" 1143:
guidelines for exposed persons. Roles of pharmacists and pharmacies have also expanded to meet the needs of public during public health emergencies.
4155: 5801: 1019:(indirect acting). The DAA drugs against hepatitis C are taken orally, as tablets, for 8 to 12 weeks. The treatment depends on the type or types ( 480:, by blocking a pocket on the surface of the virus that controls the uncoating process. This pocket is similar in most strains of rhinoviruses and 3842:"Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis" 3705: 5859: 5779: 5164: 572:
An improved knowledge of the action of reverse transcriptase has led to better nucleoside analogues to treat HIV infections. One of these drugs,
8918: 5864: 6983: 5812: 5213: 1124: 3765:"Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus" 8472: 7589: 5834: 5818: 1239: 7124: 6187: 6182: 4177: 7047: 5829: 4958: 1584:
Bryan-Marrugo, O. L.; Ramos-Jiménez, J.; Barrera-Saldaña, H.; Rojas-Martínez, A.; Vidaltamayo, R.; Rivas-Estilla, A. M. (1 July 2015).
1128: 1105:). In this context it serves to distinguish these drugs from those with an indirect mechanism of action such as immune modulators like 897: 565:, is a nucleoside analogue, and is effective against herpesvirus infections. The first antiviral drug to be approved for treating HIV, 4918: 2082: 1139:, recommend, among other things, antiviral treatment regimens, clinical assessment algorithms for coordination of care, and antiviral 699:
a host to attack pathogens by generating specialized proteins that block viral replication at various phases of the viral life cycle.
5839: 640:, and other antisense antivirals are in development. An antisense structural type that has proven especially valuable in research is 2532:"The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications" 840:(Tamiflu) that have been recently introduced to treat influenza prevent the release of viral particles by blocking a molecule named 6863: 6273: 6106: 3721:"Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits" 1741:
Bobrowski T, Melo-Filho CC, Korn D, Alves VM, Popov KI, Auerbach S, Schmitt C, Moorman NJ, Muratov EN, Tropsha A (September 2020).
1684:"Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary" 909:
on financial or locational reasons which can prevent the effectiveness of herd immunity, making effective antivirals a necessity.
7582: 5750: 9253: 9240: 7854: 7610: 2903: 1790: 1352:
Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, Spitsin S, Hanlon CA, Rupprecht C, Dietzschold B, Golovkin M, Koprowski H (2003).
960:, the swapping of viral gene segments among viruses in the same cell, also play a role in resistance, especially in influenza. 1438:
Kausar S, Said Khan F, Ishaq Mujeeb Ur Rehman M, Akram M, Riaz M, Rasool G, Hamid Khan A, Saleem I, Shamim S, Malik A (2021).
8525: 7540: 6807: 6205: 6096: 4531: 3156: 2496: 2002: 1878: 1558: 773: 257: 7867: 2530:
Flint, O. P.; Noor, M. A.; Hruz, P. W.; Hylemon, P. B.; Yarasheski, K.; Kotler, D. P.; Parker, R. A.; Bellamine, A. (2009).
9042: 8500: 4818: 4811: 2305:
Neuman, B. W.; Stein, D. A.; Kroeker, A. D.; Paulino, A. D.; Moulton, H. M.; Iversen, P. L.; Buchmeier, M. J. (June 2004).
2160:"Inhibition of Flavivirus Infections by Antisense Oligomers Specifically Suppressing Viral Translation and RNA Replication" 1157: 632:
antisense segments to these target sections blocks the operation of those genomes. A phosphorothioate antisense drug named
229: 1682:
Xu, Shujing; Ding, Dang; Zhang, Xujie; Sun, Lin; Kang, Dongwei; Huang, Boshi; Liu, Xinyong; Zhan, Peng (27 January 2022).
912:
The three FDA-approved neuraminidase antiviral flu drugs available in the United States, recommended by the CDC, include:
8179: 7185: 5854: 5191: 152:
medical profession to deal with the human immunodeficiency virus (HIV), the cause of acquired immunodeficiency syndrome (
2307:"Antisense Morpholino-Oligomers Directed against the 5' End of the Genome Inhibit Coronavirus Proliferation and Growth†" 9245: 5869: 4561: 4424: 1244: 17: 8249: 354:
Viral life cycles vary in their precise details depending on the type of virus, but they all share a general pattern:
236: 8675: 8670: 7170: 6333: 5425: 5206: 4185: 2395:
Bai J, Rossi J, Akkina R (March 2001). "Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy".
1946:"Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles" 720: 707:
Interference with post translational modifications or with targeting of viral proteins in the cell is also possible.
390:
Using agents which mimic the virus-associated protein (VAP) and bind to the cellular receptors. This may include VAP
276: 8280: 3261:"The relationship between mutation frequency and replication strategy in positive sense single-stranded RNA viruses" 9214: 8754: 8161: 7777: 7557: 6824: 6222: 5879: 5763: 619:(mRNA) molecules that direct the synthesis of viral proteins. Production of mRNA is initiated by proteins known as 1586:"History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C" 8348: 5889: 5874: 5537: 5525: 4714: 4170: 3188: 2207:
Kinney, R. M.; Huang, C. Y.-H.; Rose, B. C.; Kroeker, A. D.; Dreher, T. W.; Iversen, P. L.; Stein, D. A. (2005).
776:. In cell culture, DRACO was reported to have broad-spectrum efficacy against many infectious viruses, including 210: 4050: 2356:"Identification of the most accessible sites to ribozymes on the hepatitis C virus internal ribosome entry site" 243: 9089: 8687: 8406: 8384: 7815: 5769: 1136: 844:
that is found on the surface of flu viruses, and also seems to be constant across a wide range of flu strains.
214: 9057: 7755: 6841: 6251: 583:—which is a component of reverse transcriptase that splits the synthesized DNA from the original viral RNA. 530:
A second approach is to target the processes that synthesize virus components after a virus invades a cell.
46: 9084: 8237: 8000: 7715: 6856: 6266: 5199: 4413: 4195: 3234: 1165: 1152: 1062: 877:
in babies, and antibodies purified from infected individuals are also used as a treatment for hepatitis B.
225: 7909: 2859:
Nokes JD, Cane PA (December 2008). "New strategies for control of respiratory syncytial virus infection".
900:(CDC) inclusively recommends anyone six months and older to get a yearly vaccination to protect them from 595:, which integrate the synthesized DNA into the host cell genome. Examples of integrase inhibitors include 9126: 8997: 8933: 8901: 8849: 8146: 8128: 5024: 874: 510: 38: 3931:"Challenges of the Pandemic Response in Primary Care during Pre-Vaccination Period: A Qualitative Study" 2720:"Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65" 8682: 8095: 7835: 4674: 4163: 623:. Several antivirals are now being designed to block attachment of transcription factors to viral DNA. 31: 3796:
Simmons, Bryony; Saleem, Jawaad; Heath, Katherine; Cooke, Graham S.; Hill, Andrew (1 September 2015).
2432:"Megalomycin C, a macrolide antibiotic that blocks protein glycosylation and shows antiviral activity" 9186: 9176: 8871: 8807: 8530: 8495: 8298: 8275: 8061: 7874: 1541:
Bule, Mohammed; Khan, Fazlullah; Niaz, Kamal (6 June 2019). "Antivirals: Past, Present and Future".
9301: 9004: 8866: 8741: 8595: 7710: 7700: 7160: 6306: 6046: 5956: 5824: 5785: 1075: 885: 70: 9191: 9109: 8975: 8505: 8303: 8010: 7948: 7782: 7750: 7545: 7297: 6849: 6812: 6259: 6210: 5806: 4729: 4407: 4258: 1220: 1109:. This difference is of particular relevance for potential drug resistance mutation development. 1069:
called sustained virological response (SVR). SVR is achieved in a patient when hepatitis C virus
203: 7862: 3929:
Kunin, Marina; Engelhard, Dan; Thomas, Shane; Ashworth, Mark; Piterman, Leon (15 October 2015).
8778: 8563: 8313: 8186: 7792: 7649: 7639: 7409: 7394: 7180: 7175: 6427: 5884: 4766: 4521: 93:. Most antivirals are considered relatively harmless to the host, and therefore can be used to 726:
Protease inhibitors have also been seen in nature. A protease inhibitor was isolated from the
9099: 8731: 8600: 8108: 8015: 7934: 7356: 7351: 7165: 6759: 6708: 6564: 6081: 5894: 5774: 5644: 5243: 4451: 4387: 4232: 2209:"Inhibition of Dengue Virus Serotypes 1 to 4 in Vero Cell Cultures with Morpholino Oligomers" 1204: 1168:(SNS) consists of bulk quantities of medicines and supplies for use during such emergencies. 555: 502: 299: 90: 7879: 3841: 1078:), however, the benefits of achieving SVR may be less pronounced, though still substantial. 305:
The target proteins can be manufactured in the lab for testing with candidate treatments by
250: 9181: 9074: 9020: 8948: 8938: 8630: 8485: 8358: 7965: 7574: 7155: 6703: 6560: 5964: 5790: 5639: 5397: 4526: 4506: 4375: 3993: 2976: 2669: 2086: 1365: 1086: 926: 636:
has been introduced, used to treat opportunistic eye infections in AIDS patients caused by
620: 401:
Using agents which mimic the cellular receptor and bind to the VAP. This includes anti-VAP
348: 160: 5221: 3656:
Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS (May 2017).
8: 9268: 9258: 9224: 8829: 8267: 8103: 7914: 6689: 6652: 6404: 5899: 5758: 5630: 5548: 5347: 5226: 5135: 4871: 4657: 4436: 4263: 3604: 2258:"A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice" 1215: 1198: 514: 466:
have been introduced to combat influenza. These agents act on penetration and uncoating.
306: 109: 3997: 3605:
Gonzålez-Grande R, Jiménez-Pérez M, Gonzålez Arjona C, Mostazo Torres J (January 2016).
3049: 2673: 1901:
Bishop NE (1998). "Examination of potential inhibitors of hepatitis A virus uncoating".
1625: 1369: 405:, receptor anti-idiotypic antibodies, extraneous receptor and synthetic receptor mimics. 8992: 8987: 8896: 8876: 8510: 8353: 8318: 8172: 8138: 7688: 7346: 7251: 6754: 5169: 5034: 4893: 4347: 4016: 3981: 3957: 3930: 3824: 3797: 3747: 3720: 3682: 3658:"Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review" 3657: 3633: 3606: 3565: 3540: 3521: 3467: 3442: 3374: 3349: 3285: 3260: 3121: 3025: 3000: 2931: 2884: 2841: 2692: 2657: 2556: 2531: 2507: 2461: 2287: 2233: 2208: 2184: 2159: 2069:"A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques" 1926: 1884: 1838: 1813: 1767: 1742: 1718: 1683: 1661: 1583: 1569: 1515: 1488: 1464: 1439: 1314: 1287: 1161: 1066: 953: 380: 7924: 3907: 2744: 2719: 2331: 2306: 1970: 1945: 1388: 1353: 9306: 9278: 9219: 9079: 9032: 8834: 8336: 8005: 7995: 7985: 7970: 7787: 7770: 7634: 7507: 6041: 5704: 5175: 5130: 4913: 4903: 4806: 4636: 4592: 4576: 4380: 4370: 4313: 4303: 4021: 3962: 3911: 3687: 3638: 3570: 3525: 3513: 3472: 3420: 3379: 3330: 3290: 3162: 3152: 3113: 3071: 3030: 2923: 2876: 2845: 2833: 2798: 2793: 2768: 2749: 2697: 2638: 2634: 2602: 2597: 2580: 2561: 2512: 2492: 2453: 2448: 2431: 2412: 2377: 2336: 2322: 2279: 2238: 2189: 2140: 2049: 2044: 2019: 1998: 1975: 1918: 1888: 1874: 1843: 1772: 1723: 1705: 1665: 1653: 1645: 1605: 1554: 1520: 1469: 1420: 1393: 1319: 1268: 1132: 813:
in the cascade, and cleave a variety of cellular proteins, thereby killing the cell.
734:). The presence of this may explain the Shiitake mushrooms' noted antiviral activity 671: 3125: 3050:"Targeting pandemic influenza: a primer on influenza antivirals and drug resistance" 2939: 2935: 2735: 2465: 2224: 2175: 1961: 1930: 1304: 9273: 9209: 9196: 9025: 9014: 8906: 8886: 8721: 8635: 8610: 8341: 8288: 8227: 8118: 7765: 7693: 7366: 6066: 5140: 4963: 4888: 4876: 4801: 4667: 4546: 4335: 4134: 4011: 4001: 3952: 3942: 3903: 3876: 3819: 3809: 3776: 3742: 3732: 3677: 3669: 3628: 3618: 3560: 3552: 3503: 3462: 3454: 3410: 3369: 3361: 3320: 3280: 3272: 3144: 3105: 3061: 3020: 3012: 2915: 2888: 2868: 2825: 2788: 2780: 2739: 2731: 2687: 2677: 2630: 2592: 2551: 2543: 2502: 2484: 2443: 2404: 2367: 2326: 2318: 2291: 2269: 2228: 2220: 2179: 2171: 2132: 2039: 2031: 1965: 1957: 1910: 1866: 1833: 1825: 1762: 1754: 1713: 1695: 1637: 1597: 1564: 1546: 1510: 1500: 1459: 1451: 1383: 1373: 1309: 1299: 1140: 176: 159:
The first experimental antivirals were developed in the 1960s, mostly to deal with
141: 137: 6240: 4607: 4076: 4044:
Public Health Use and Distribution of Antivirals: NACCHO Think Tank Meeting Report
3399:"Antiviral resistance: mechanisms, clinical significance, and future implications" 2784: 9141: 9136: 8980: 8928: 8736: 8713: 8558: 8535: 7919: 7884: 7760: 7705: 6887: 6883: 6581: 6343: 6297: 6293: 6142: 6101: 5261: 5180: 5125: 4994: 4989: 4828: 4761: 4756: 4642: 4588: 4429: 4320: 4273: 4006: 3148: 2872: 2682: 2479:
Anderson J, Schiffer C, Lee SK, Swanstrom R (2009). "Viral Protease Inhibitors".
2372: 2355: 2109: 1870: 1758: 1641: 1550: 1106: 1094: 853: 660: 637: 509:
Rhinoviruses are the most common cause of the common cold; other viruses such as
419: 164: 94: 62: 7889: 3706:"Table of Surrogate Endpoints That Were the Basis of Drug Approval or Licensure" 2488: 1992: 687:
Yet another antiviral technique inspired by genomics is a set of drugs based on
9171: 9104: 9047: 8708: 8700: 8625: 8578: 8573: 8520: 8244: 8025: 8020: 7980: 7929: 7894: 7732: 7668: 7551: 7491: 7070: 6818: 6370: 6216: 5159: 5059: 5054: 4908: 4898: 4848: 4833: 4823: 4724: 4719: 4709: 4619: 4571: 4566: 4298: 4253: 4249: 3982:"Antiviral Treatment among Older Adults Hospitalized with Influenza, 2006–2012" 3206: 2919: 2408: 2136: 1230: 1190: 890: 789: 489: 391: 172: 6871: 6281: 3947: 3737: 3556: 3325: 3308: 2068: 1700: 1601: 1505: 1455: 647:
Morpholino oligos have been used to experimentally suppress many viral types:
9295: 9052: 9009: 8968: 8861: 8844: 8802: 8515: 8066: 8035: 7656: 7084: 6736: 6535: 6315: 5982: 5732: 5567: 5453: 5091: 5064: 4923: 4741: 4652: 4632: 4628: 4491: 4419: 4308: 4223: 4109: 3591: 3016: 2547: 1709: 1649: 1609: 841: 765: 616: 125: 86: 74: 73:
is effective against a wide range of viruses. Antiviral drugs are a class of
7902: 3623: 3365: 2274: 2257: 2017: 1378: 9263: 9201: 8963: 8943: 8891: 8839: 8790: 8590: 8540: 8151: 7722: 7466: 7461: 7431: 7405: 7390: 7380: 7217: 7139: 7037: 6988: 6958: 6879: 6775: 6546: 6423: 6361: 6289: 6036: 6026: 5607: 5597: 5415: 5372: 5367: 5362: 5324: 5304: 5234: 5049: 4968: 4704: 4662: 4496: 4486: 4402: 4397: 4092:"Antiviral Distribution and Dispensing A Review of Legal and Policy Issues" 4025: 3966: 3915: 3691: 3642: 3574: 3517: 3476: 3415: 3398: 3383: 3334: 3294: 3276: 3166: 3117: 3075: 2927: 2880: 2837: 2829: 2802: 2715: 2701: 2606: 2565: 2516: 2416: 2381: 2340: 2283: 2242: 2193: 2144: 2053: 1922: 1847: 1776: 1727: 1657: 1524: 1473: 1424: 1397: 1354:"Function and glycosylation of plant-derived antiviral monoclonal antibody" 1323: 1272: 957: 785: 777: 604: 600: 518: 493: 3424: 3143:. Handbook of Experimental Pharmacology. Vol. 189. pp. 299–320. 3034: 2753: 2642: 2457: 2035: 1979: 1829: 1437: 615:
Once a virus genome becomes operational in a host cell, it then generates
9156: 8958: 8881: 8856: 8605: 8585: 8490: 8450: 8374: 7745: 7740: 7661: 7644: 7512: 7486: 7481: 7441: 7436: 7400: 7385: 7375: 7320: 7306: 7288: 7226: 7207: 7199: 7057: 7012: 7007: 6953: 6948: 6943: 6938: 6918: 6896: 6784: 6676: 6642: 6628: 6623: 6418: 6379: 6375: 6366: 6162: 6137: 6076: 6061: 6056: 5720: 5687: 5602: 5582: 5377: 5357: 5336: 5283: 5251: 4933: 4843: 4583: 4536: 4481: 4364: 4330: 3814: 3508: 3491: 3066: 2656:
Rider TH, Zook CE, Boettcher TL, Wick ST, Pancoast JS, Zusman BD (2011).
2483:. Handbook of Experimental Pharmacology. Vol. 189. pp. 85–110. 1812:
Lindequist, Ulrike; Niedermeyer, Timo H. J.; JĂŒlich, Wolf-Dieter (2005).
1008: 913: 905: 901: 837: 695: 676: 651: 596: 481: 477: 463: 441: 440:
cell. At least one of these entry inhibitors—a biomimetic peptide called
425: 133: 129: 120:
Most of the antiviral drugs now available are designed to help deal with
3458: 3109: 1743:"Learning from history: do not flatten the curve of antiviral research!" 772:) is a group of experimental antiviral drugs initially developed at the 9094: 9069: 9037: 8814: 8795: 8785: 8773: 8620: 8232: 8204: 8030: 7990: 7522: 7517: 7451: 7338: 7283: 7278: 7273: 7269: 7261: 7231: 7134: 7129: 7119: 7114: 7094: 7079: 7052: 7042: 7032: 7022: 6978: 6973: 6968: 6963: 6933: 6928: 6923: 6789: 6746: 6666: 6615: 6605: 6576: 6540: 6524: 6514: 6473: 6458: 6393: 6167: 6147: 6132: 6127: 6091: 6086: 6000: 5945: 5915: 5727: 5715: 5710: 5682: 5622: 5612: 5587: 5572: 5562: 5511: 5506: 5494: 5478: 5468: 5448: 5410: 5320: 5308: 5300: 5111: 5082: 5040: 5009: 5004: 4943: 4938: 4928: 4866: 4852: 4792: 4747: 4695: 4615: 4611: 4552: 4512: 4467: 4463: 4353: 4289: 4239: 4204: 4200: 3719:
Smith-Palmer, Jayne; Cerri, Karin; Valentine, William (December 2015).
3048:
Moss, Ronald; Davey, Richard; Steigbigel, Roy; Fang, Fang (June 2010).
1234: 1098: 1090: 1016: 1011:
infections. These are the more effective than older treatments such as
870: 863: 821: 793: 781: 755: 656: 641: 633: 573: 566: 543: 539: 485: 473: 469: 459: 217: in this section. Unsourced material may be challenged and removed. 105: 82: 78: 58: 4074: 3880: 3781: 3764: 1914: 1487:
Yin H, Jiang N, Shi W, Chi X, Liu S, Chen JL, Wang S (February 2021).
981: 750:
helices during transcription and replication. In contrast, uninfected
9166: 8645: 7678: 7673: 7606: 7476: 7446: 7316: 7311: 7256: 7242: 7099: 7089: 7027: 6905: 6872: 6780: 6731: 6681: 6671: 6661: 6572: 6529: 6519: 6494: 6448: 6433: 6357: 6282: 6177: 6157: 6152: 6122: 6051: 6031: 5920: 5677: 5592: 5577: 5500: 5473: 5463: 5458: 5405: 5382: 5295: 5019: 4999: 4973: 4948: 4883: 4861: 4689: 4602: 4476: 3673: 3655: 3095: 1337:
Rick Daniels; Leslie H. Nicoll. "Pharmacology – Nursing Management".
1082: 1012: 941: 921: 917: 833: 801: 751: 592: 562: 97: 3259:
Thebaud, G; Chadeouf, J; Morelli, M; McCauley, J; Haydon, D (2010).
192: 9149: 9064: 8640: 8615: 8568: 8113: 7683: 7626: 7017: 6698: 6591: 6468: 6172: 5557: 5120: 4984: 4980: 4953: 4392: 4325: 4244: 2904:"Hepatitis B immune globulin and HBV-related liver transplantation" 2714: 1997:. Hagerstwon, MD: Lippincott Williams & Wilkins. p. 1419. 1225: 1048: 1020: 769: 727: 716: 688: 402: 310: 153: 101: 931:
mutation, which is currently widespread in seasonal H1N1 strains.
809:. The procaspases transactivate via cleavage, activate additional 37:"Antiviral Therapy" redirects here. For the academic journal, see 8953: 8824: 8077: 7471: 7109: 7104: 6442: 6413: 6388: 6352: 6071: 5617: 5387: 5096: 5014: 4679: 4446: 4268: 4218: 3541:"Antiviral Drug Resistance: Mechanisms and Clinical Implications" 1054: 1036: 1030: 810: 806: 580: 333: 1863:
Medicinal Mushrooms: Recent Progress in Research and Development
9161: 8726: 8379: 7975: 7456: 7426: 6453: 6021: 6016: 4778: 4441: 3979: 3208:
Molecular Cell Biology: Viruses – Structure, Function, and Uses
2977:"Influenza Antiviral Drug Resistance| Seasonal Influenza (Flu)" 1288:"Nitazoxanide: a first-in-class broad-spectrum antiviral agent" 1042: 666: 395: 361:
Release of viral genes and possibly enzymes into the host cell.
337: 329: 325: 3838: 3258: 2157: 1626:"Overview of Recent Strategic Advances in Medicinal Chemistry" 1279: 386:
This stage of viral replication can be inhibited in two ways:
8390: 5331: 5078: 4788: 4283: 4110:"Funding and Guidance for State and Local Health Departments" 4096:
Association of State and Territorial Health Officials (ASTHO)
3893: 1993:
Beringer, Paul; Troy, David A.; Remington, Joseph P. (2006).
760: 747: 341: 321: 66: 7604: 3928: 3865: 3138: 2478: 2066: 1791:"A History of Antivirals: Mechanisms, Classes, and Subtypes" 1740: 1184: 558:(RNA to DNA) than with "normal" transcriptase (DNA to RNA). 7843: 7067: 6998: 6909: 5845:
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
5290: 5278: 4782: 3761: 2256:
McCaffrey AP, Meuse L, Karimi M, Contag CH, Kay MA (2003).
1811: 579:
Another target being considered for HIV antivirals include
433: 367:
Assembly of viral components into complete viral particles.
5850:
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil
3718: 3440: 2255: 2110:"Development of polyvalent inactivated rhinovirus vaccine" 364:
Replication of viral components using host-cell machinery.
5315: 5230: 3200: 3198: 2619: 2304: 2122: 2018:
Daniel C. Pevear; Tina M. Tull; Martin E. Seipel (1999).
1444:
International Journal of Immunopathology and Pharmacology
1102: 1070: 974: 796:, and was additionally found effective against influenza 551: 547: 429: 121: 5796:
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide
3492:"Global transmission of oseltamivir-resistant influenza" 1410: 1336: 3795: 3047: 2429: 1003:(DAA) has long been associated with the combination of 754:
cells generally produce dsRNA helices of fewer than 24
316: 3195: 2655: 2206: 1943: 1489:"Development and Effects of Influenza Antiviral Drugs" 1210:
Discovery and development of CCR5 receptor antagonists
4188:
Anatomical Therapeutic Chemical Classification System
3441:
Irwin, K; Renzette, N; Kowalik, T; Jensen, J (2016).
3181:"WHO | Antiviral use and the risk of drug resistance" 1818:
Evidence-Based Complementary and Alternative Medicine
456:
Inhibitors of uncoating have also been investigated.
2529: 1180: 967: 370:
Release of viral particles to infect new host cells.
2718:; Griffiths G; Ericsson M; Moss B; Doms RW (1994). 2623:
Biochemical and Biophysical Research Communications
2578: 982:
Treatment options for antiviral resistant pathogens
702: 3443:"Antiviral drug resistance as an adaptive process" 3204: 1440:"A review: Mechanism of action of antiviral drugs" 1351: 800:in weanling mice. It was reported to induce rapid 3708:. Food and Drug Administration. 28 February 2022. 3350:"Emerging influenza antiviral resistance threats" 1986: 1860: 934: 862:One of the best-known of this class of drugs are 9293: 5802:Dolutegravir/emtricitabine/tenofovir alafenamide 3607:"New approaches in the treatment of hepatitis C" 3532: 3483: 3431: 3396: 3252: 3228: 3226: 546:analogues that look like the building blocks of 30:"Antiviral" redirects here. For other uses, see 5860:Emtricitabine/rilpivirine/tenofovir alafenamide 5780:Bictegravir/emtricitabine/tenofovir alafenamide 3436: 3434: 3211:. New York, New York: W. H. Freeman and Company 2987: 1995:Remington, the science and practice of pharmacy 1944:Almela MJ, GonzĂĄlez ME, Carrasco L (May 1991). 1622: 5974: 5865:Emtricitabine/rilpivirine/tenofovir disoproxil 5351:(Integrase strand transfer inhibitors (INSTI)) 2994: 2992: 2990: 2394: 2020:"Activity of Pleconaril against Enteroviruses" 1681: 1486: 7956: 7590: 6857: 6267: 5813:Dolutegravir/lamivudine/tenofovir alafenamide 5207: 4171: 3538: 3347: 3223: 741: 398:of the receptor and anti-receptor antibodies. 5835:Efavirenz/emtricitabine/tenofovir disoproxil 5819:Dolutegravir/lamivudine/tenofovir disoproxil 4186:Major chemical drug groups – based upon the 4075:Centers for Disease Control and Prevention. 3887: 3649: 3598: 3594:. National Health Service, UK. 21 June 2018. 3309:"Viruses are models for embracing diversity" 2998: 2572: 2388: 2347: 2298: 2249: 2200: 2151: 2116: 1894: 1814:"The Pharmacological Potential of Mushrooms" 1734: 1540: 1285: 1240:Discovery and development of NS5A inhibitors 940:immunocompetent patients, hospitalized with 880: 847: 3545:Infectious Disease Clinics of North America 2708: 2613: 2430:AlarcĂłn B, GonzĂĄlez ME, Carrasco L (1988). 2083:"Common Cold Causes: Rhinoviruses and More" 1937: 1480: 1431: 1045:(sofosbuvir, velpatasvir, and voxilaprevir) 994: 7597: 7583: 6864: 6850: 6274: 6260: 5830:Doravirine/lamivudine/tenofovir disoproxil 5214: 5200: 4178: 4164: 4139:Centers for Disease Control and Prevention 4114:Centers for Disease Control and Prevention 4089: 3348:Hayden, FG; de Jong, MD (1 January 2011). 3232: 2901: 1129:Centers for Disease Control and Prevention 898:Centers for Disease Control and Prevention 869:A more specific approach is to synthesize 715:Some viruses include an enzyme known as a 27:Medication used to treat a viral infection 5840:Efavirenz/lamivudine/tenofovir disoproxil 4037: 4035: 4015: 4005: 3956: 3946: 3861: 3859: 3823: 3813: 3780: 3746: 3736: 3681: 3632: 3622: 3564: 3507: 3466: 3414: 3403:The Journal of Antimicrobial Chemotherapy 3397:Kimberlin, DW; Whitley, RJ (March 1996). 3373: 3324: 3284: 3065: 3024: 2858: 2792: 2766: 2743: 2691: 2681: 2596: 2555: 2506: 2447: 2371: 2330: 2273: 2232: 2183: 2107: 2067:Lee, S.; Nguyen, M.; Currier, M. (2016). 2043: 1969: 1900: 1837: 1766: 1717: 1699: 1568: 1514: 1504: 1463: 1387: 1377: 1313: 1303: 525: 424:A very early stage of viral infection is 309:that synthesizes the target protein into 277:Learn how and when to remove this message 6107:Zinc finger protein transcription factor 5937: 3935:Israel Journal of Health Policy Research 3205:Lodish, H; Berk, A; Zipursky, S (2000). 3041: 1026:The DAA combination drugs used include: 904:viruses (H1N1) and (H3N2) and up to two 682: 626: 533: 182: 45: 8671:Ear-Nose-Throat/Upper respiratory tract 7844:Access to water, sanitation and hygiene 3489: 3235:"The error-prone ways of RNA synthesis" 2815: 2658:"Broad-spectrum antiviral therapeutics" 1865:, Springer Singapore, pp. 275–97, 1117: 451: 168:effect were selected for closer study. 14: 9294: 9254:Infectious disease (medical specialty) 9146:Antimicrobial resistance surveillance 5165:Pharmacological classification systems 4532:Selective estrogen receptor modulators 4041: 4032: 3856: 3586: 3584: 2971: 2969: 2967: 2965: 2963: 2961: 2959: 2957: 2579:Odani S, Tominaga K, Kondou S (1999). 2353: 2108:Tang, Roderick; Moore, Martin (2017). 1341:. Cengage Learning, 2011. p. 397. 710: 569:(AZT), is also a nucleoside analogue. 289: 7578: 6845: 6255: 5195: 4812:Non-steroidal anti-inflammatory drugs 4159: 3896:Current Topics in Medicinal Chemistry 3054:Journal of Antimicrobial Chemotherapy 2024:Antimicrobial Agents and Chemotherapy 1677: 1675: 1339:Contemporary Medical-Surgical Nursing 774:Massachusetts Institute of Technology 77:, a larger group which also includes 8501:Compartmental models in epidemiology 4135:"Strategic National Stockpile (SNS)" 1536: 1534: 1158:Public Health Emergency Preparedness 538:One way of doing this is to develop 374: 317:Approaches by virus life cycle stage 215:adding citations to reliable sources 186: 100:. They should be distinguished from 7186:Sofosbuvir/velpatasvir/voxilaprevir 5992: 5855:Emtricitabine/tenofovir alafenamide 4425:Angiotensin II receptor antagonists 3581: 3233:Racaniello, Vincent (10 May 2009). 2954: 978:emergence of antiviral resistance. 175:. Only in the 1980s, when the full 163:, and were found using traditional 89:drugs, or antiviral drugs based on 24: 7301: 5870:Emtricitabine/tenofovir disoproxil 3354:The Journal of Infectious Diseases 2902:Akay S, Karasu Z (November 2008). 2769:"Antiviral Actions of Interferons" 1672: 1543:Recent Advances in Animal Virology 1245:COVID-19 drug repurposing research 1015:(partially indirectly acting) and 694:A ribozyme antiviral to deal with 413: 65:. Most antivirals target specific 25: 9318: 7171:Ombitasvir/paritaprevir/ritonavir 3908:10.2174/1568026621666211012110819 3611:World Journal of Gastroenterology 1531: 968:Detection of antiviral resistance 9250:Economics of Infectious Diseases 6243:. Formerly or rarely used agent. 5880:Lamivudine/nevirapine/zidovudine 5764:Abacavir/dolutegravir/lamivudine 5174: 5154: 5153: 2598:10.1046/j.1432-1327.1999.00463.x 2585:European Journal of Biochemistry 2323:10.1128/JVI.78.11.5891-5899.2004 1183: 1112: 1065:approved DAAs on the basis of a 827: 703:Protein processing and targeting 610: 561:The first successful antiviral, 340:), and sometimes covered with a 191: 6047:Epigallocatechin gallate (EGCG) 5890:Lamivudine/tenofovir disoproxil 5875:Lamivudine/nevirapine/stavudine 4562:Hypothalamic–pituitary hormones 4127: 4102: 4083: 4068: 3973: 3922: 3832: 3789: 3755: 3712: 3698: 3496:New England Journal of Medicine 3390: 3341: 3301: 3173: 3132: 3089: 2895: 2852: 2816:Burra P (2009). "Hepatitis C". 2809: 2760: 2736:10.1128/JVI.68.2.1103-1114.1994 2649: 2523: 2472: 2423: 2225:10.1128/JVI.79.8.5116-5128.2005 2176:10.1128/JVI.79.8.4599-4609.2005 2125:Antisense Nucleic Acid Drug Dev 2101: 2075: 2060: 2011: 1962:10.1128/JVI.65.5.2572-2577.1991 1854: 1805: 1783: 1616: 1305:10.1016/j.antiviral.2014.07.014 1164:. Also managed by the CDC, the 202:needs additional citations for 115: 9259:Infectious disease informatics 9090:Transmission-based precautions 5770:Abacavir/lamivudine/zidovudine 3539:Strasfeld, L; Chou, S (2010). 1630:Journal of Medicinal Chemistry 1577: 1493:Molecules (Basel, Switzerland) 1404: 1345: 1330: 1257: 1146: 1057:(glecaprevir and pibrentasvir) 935:Origin of antiviral resistance 893:, including antiviral agents. 13: 1: 8676:Chest/Lower respiratory tract 8451:Ocular (Eye) mucosal membrane 7812:Behavioral/lifestyle factors 6912:protease inhibitors (–previr) 6600: 4314:Thrombolytics / fibrinolytics 3763:Lawitz, Eric (January 2015). 2999:Pillay, D; Zambon, M (1998). 2785:10.1128/CMR.14.4.778-809.2001 1250: 347:Researchers working on such " 81:(also termed antibacterial), 8238:Aerosol-generating procedure 8016:Silent/Subclinical infection 7716:Multidrug-resistant bacteria 5025:Wakefulness-promoting agents 4090:Hodge, J G; Orenstein, D G. 4007:10.1371/journal.pone.0121952 3802:Clinical Infectious Diseases 3149:10.1007/978-3-540-79086-0_11 2873:10.1097/QCO.0b013e3283184245 2683:10.1371/journal.pone.0022572 2635:10.1016/0006-291X(89)91665-3 2449:10.1016/0014-5793(88)80732-4 2373:10.5483/BMBRep.2003.36.6.538 1871:10.1007/978-981-13-6382-5_10 1759:10.1016/j.drudis.2020.07.008 1642:10.1021/acs.jmedchem.9b00359 1551:10.1007/978-981-13-9073-9_22 1166:Strategic National Stockpile 1153:Strategic National Stockpile 1103:human immunodeficiency virus 1063:Food and Drug Administration 1039:(sofosbuvir and velpatasvir) 824:acts at the assembly phase. 586: 484:, which can cause diarrhea, 332:stored in a capsule made of 50:Antiretroviral drugs for HIV 7: 8902:Vaccine-preventable disease 8850:Monoclonal antibody therapy 5645:Tenofovir alafenamide (TAF) 3662:Annals of Internal Medicine 3001:"Antiviral Drug Resistance" 2489:10.1007/978-3-540-79086-0_4 2397:AIDS Res. Hum. Retroviruses 1176: 1033:(sofosbuvir and ledipasvir) 889:all specific and effective 875:respiratory syncytial virus 816: 511:respiratory syncytial virus 39:Antiviral Therapy (journal) 10: 9323: 9043:Respiratory source control 5640:Tenofovir disoproxil (TDF) 4675:Intravenous immunoglobulin 2920:10.1517/14712598.8.11.1815 2767:Samuel CE (October 2001). 2409:10.1089/088922201750102427 2137:10.1089/108729001753231696 1201:(especially HAART for HIV) 1150: 1051:(elbasvir and grazoprevir) 851: 746:Most viruses produce long 742:Long dsRNA helix targeting 417: 358:Attachment to a host cell. 36: 32:Antiviral (disambiguation) 29: 9233: 9187:Global Health Initiatives 9177:Evolutionary epidemiology 9125: 8917: 8872:Post-exposure prophylaxis 8808:Antimicrobial stewardship 8766: 8753: 8658: 8549: 8531:Multiplicity of infection 8496:Basic reproduction number 8471: 8443: 8429: 8415: 8399: 8367: 8329: 8272:Percutaneous inoculation 8258: 8220: 8213: 8195: 8127: 8094: 8087: 8051: 8044: 7947: 7834: 7756:Host–pathogen interaction 7731: 7625: 7618: 7535: 7500: 7419: 7365: 7337: 7330: 7240: 7216: 7198: 7148: 7066: 6997: 6904: 6895: 6802: 6768: 6745: 6724: 6717: 6641: 6614: 6590: 6559: 6507: 6487: 6403: 6342: 6332: 6323: 6314: 6305: 6200: 6115: 6009: 5991: 5973: 5955: 5936: 5929: 5908: 5749: 5696: 5670: 5661:Discovery and development 5653: 5536: 5524: 5487: 5441: 5432:Discovery and development 5424: 5396: 5346: 5268:Discovery and development 5260: 5242: 5149: 5105: 5077: 5033: 4842: 4777: 4740: 4688: 4601: 4545: 4505: 4462: 4346: 4282: 4194: 3948:10.1186/s13584-015-0028-5 3738:10.1186/s12879-015-0748-8 3557:10.1016/j.idc.2010.01.001 3326:10.1038/s41564-018-0145-3 1701:10.3390/molecules27030850 1602:10.1016/j.rmu.2015.05.003 1506:10.3390/molecules26040810 1456:10.1177/20587384211002621 881:Antiviral drug resistance 848:Immune system stimulation 9005:Protective sequestration 8867:Pre-exposure prophylaxis 8158:Generational difference 7711:Horizontal gene transfer 7701:Antimicrobial resistance 7298:neuraminidase inhibitors 7161:Glecaprevir/pibrentasvir 5957:Transcription inhibitors 5909:Pharmacokinetic boosters 5825:Dolutegravir/rilpivirine 5786:Cabotegravir/rilpivirine 5426:Protease Inhibitors (PI) 4730:Topoisomerase inhibitors 4414:renin–angiotensin system 4408:Calcium channel blockers 4049:(Report). Archived from 4042:NACCHO (December 2010). 3017:10.1136/bmj.317.7159.660 2910:(Submitted manuscript). 2548:10.1177/0192623308327119 2071:. Nature Communications. 1125:local health departments 1076:hepatocellular carcinoma 1001:Direct-acting antivirals 995:Direct-acting antivirals 71:broad-spectrum antiviral 9192:Microbial phylogenetics 9110:Wastewater surveillance 8631:Geographic distribution 8506:Critical community size 8304:Surgical site infection 8152:Iatrogenic/Medical care 8071:Microbial translocation 8067:Endogenous reactivation 8062:Normal flora overgrowth 8011:Opportunistic infection 7783:Opportunistic infection 6725:Nucleic acid inhibitors 6241:initial regimen options 5807:Dolutegravir/lamivudine 5284:Enfuvirtide (ENF, T-20) 5262:Entry/fusion inhibitors 3725:BMC Infectious Diseases 3624:10.3748/wjg.v22.i4.1421 2861:Curr. Opin. Infect. Dis 2354:Ryu KJ, Lee SW (2003). 2275:10.1053/jhep.2003.50330 1379:10.1073/pnas.0832472100 1221:List of antiviral drugs 780:, Amapari and Tacaribe 9264:Microbial bioterrorism 8887:efficacy/effectiveness 8295:Surgical intervention 8187:Breakthrough infection 7809:Genetic predisposition 7793:Susceptible individual 7640:Germ theory of disease 7501:Multiple/Unknown/Other 7270:adamantane derivatives 7181:Sofosbuvir/velpatasvir 7176:Sofosbuvir/daclatasvir 6082:Portmanteau inhibitors 5975:Translation inhibitors 5885:Lamivudine/raltegravir 5655:Non-nucleoside (NNRTI) 5613:Islatravir (EFdA, ISL) 4522:Hormonal contraception 4452:Bile acid sequestrants 4233:Proton-pump inhibitors 4196:gastrointestinal tract 3592:"Overview-Hepatitis C" 3277:10.1098/rspb.2009.1247 2830:10.1055/s-0029-1192055 1590:Medicina Universitaria 758:during transcription. 526:During viral synthesis 51: 9100:Universal precautions 8058:Endogenous overgrowth 7910:Poultry and livestock 7369:inhibitors (–trelvir) 7357:Peginterferon alfa-2b 7352:Peginterferon alfa-2a 7166:Ledipasvir/sofosbuvir 6760:Peginterferon alfa-2a 6709:Tenofovir alafenamide 6097:Synergistic enhancers 5895:Lamivudine/zidovudine 5775:Atazanavir/cobicistat 5751:Combined formulations 5588:Zidovudine (AZT, ZDV) 5526:Reverse-transcriptase 5398:Maturation inhibitors 3366:10.1093/infdis/jiq012 2908:Expert Opin Biol Ther 2360:J. Biochem. Mol. Biol 2036:10.1128/AAC.43.9.2109 1450:: 20587384211002621. 1286:Rossignol JF (2014). 683:Translation/ribozymes 627:Translation/antisense 621:transcription factors 556:reverse transcriptase 534:Reverse transcription 503:Nature Communications 300:computer-aided design 183:Antiviral drug design 91:monoclonal antibodies 49: 9202:Genomic reassortment 9182:Genetic epidemiology 9021:Health communication 8949:Flattening the curve 8939:Disease surveillance 8722:Systemic/Generalized 8486:Animal disease model 7966:Asymptomatic carrier 7156:Elbasvir/grazoprevir 6704:Tenofovir disoproxil 6690:Nucleotide analogues 6653:Nucleoside analogues 5938:Uncoating inhibitors 5791:Darunavir/cobicistat 5631:Nucleotide analogues 5549:Nucleoside analogues 5348:Integrase inhibitors 5227:antiretroviral drugs 5131:Radiopharmaceuticals 4919:Antiparkinson agents 3509:10.1056/NEJMp0900648 3416:10.1093/jac/37.3.403 3191:on 1 September 2014. 3141:Antiviral Strategies 3098:Nature Biotechnology 2773:Clin. Microbiol. Rev 2481:Antiviral Strategies 1747:Drug Discovery Today 1545:. pp. 425–446. 1170:Antiviral stockpiles 1118:Use and distribution 1087:herpes simplex virus 927:Nature Biotechnology 886:Antiviral resistance 452:Uncoating inhibitors 394:antibodies, natural 349:rational drug design 328:and sometimes a few 211:improve this article 110:Australian tea trees 9269:Pandemic prevention 9225:Viral phylodynamics 9206:Re-emerging disease 9095:Travel restrictions 8299:Postoperative wound 8268:Blood-borne disease 8250:Respiratory droplet 8162:Vertical/Congenital 8147:Nosocomial/Hospital 8104:Spillover infection 7073:inhibitors (–buvir) 7001:inhibitors (–asvir) 6405:Pyrimidine analogue 5930:Experimental agents 5900:Lopinavir/ritonavir 5759:Abacavir/lamivudine 5733:Elsulfavirine (ESV) 5568:Emtricitabine (FTC) 5454:Fosamprenavir (FPV) 4914:Antimigraine agents 4904:Antidementia agents 4807:Anti-inflammatories 4497:Medicated dressings 4437:Antihyperlipidemics 4264:Diabetes medication 3998:2015PLoSO..1021952L 3490:Moscona, A (2009). 3313:Nature Microbiology 3110:10.1038/nbt0609-510 2674:2011PLoSO...622572R 2164:Journal of Virology 1830:10.1093/ecam/neh107 1370:2003PNAS..100.8013K 1216:Monoclonal antibody 1199:Antiretroviral drug 766:double-stranded RNA 721:protease inhibitors 711:Protease inhibitors 515:parainfluenza virus 290:Antiviral targeting 9215:Selection pressure 8511:Force of infection 8139:Contagious disease 8074:Endogenous seeding 7971:Chain of infection 7895:Injection drug use 7806:Vaccination status 7689:Case fatality rate 7607:infectious disease 7562:Never to phase III 7420:RNA pol inhibitors 7347:Interferon alfa 2b 7252:Baloxavir marboxil 6829:Never to phase III 6755:Interferon alfa 2b 6227:Never to phase III 5373:Elvitegravir (EVG) 5368:Dolutegravir (DTG) 5363:Cabotegravir (CAB) 4767:Immunosuppressants 4637:Antimycobacterials 4593:Antithyroid agents 4577:Mineralocorticoids 4381:Cardiac stimulants 4371:Cardiac glycosides 4363:cardiac therapy / 4259:Anti-obesity drugs 4056:on 22 October 2016 3815:10.1093/cid/civ396 3067:10.1093/jac/dkq100 2983:. 25 October 2018. 1162:pandemic influenza 1067:surrogate endpoint 1061:The United States 954:quasispecies model 768:activated caspase 591:Another target is 476:, which cause the 307:inserting the gene 61:used for treating 52: 18:Anti-viral therapy 9289: 9288: 9279:Tropical medicine 9220:Synthetic biology 9121: 9120: 9080:Social distancing 9033:Outbreak response 8654: 8653: 8481:Agent-based model 8467: 8466: 8463: 8462: 8459: 8458: 8006:Natural reservoir 7996:Infectious period 7986:Incubation period 7943: 7942: 7899:Natural disaster 7868:Tropical diseases 7851:Biodiversity loss 7788:Risk of infection 7778:Microbiome health 7771:Immunosuppression 7572: 7571: 7531: 7530: 7194: 7193: 7149:Combination drugs 6839: 6838: 6798: 6797: 6637: 6636: 6555: 6554: 6503: 6502: 6483: 6482: 6249: 6248: 6196: 6195: 6042:Diarylpyrimidines 5745: 5744: 5741: 5740: 5721:Rilpivirine (RPV) 5705:diarylpyrimidines 5688:Delavirdine (DLV) 5583:Zalcitabine (ddC) 5540:nucleotide (NRTI) 5520: 5519: 5378:Raltegravir (RAL) 5358:Bictegravir (BIC) 5337:Fostemsavir (FTR) 5252:Lenacapavir (LEN) 5244:Capsid inhibitors 5189: 5188: 5092:Ophthalmologicals 4802:Anabolic steroids 4705:Anticancer agents 4668:Ectoparasiticides 4388:Antihypertensives 4336:Antifibrinolytics 3902:(30): 2687–2693. 3881:10.1002/hep.29408 3782:10.1002/hep.27366 3459:10.1093/ve/vew014 3158:978-3-540-79085-3 2942:on 3 October 2021 2498:978-3-540-79085-3 2089:on 8 January 2022 2004:978-0-7817-4673-1 1915:10.1159/000024948 1880:978-981-13-6382-5 1636:(21): 9375–9414. 1560:978-981-13-9072-2 1133:2009 flu pandemic 1131:(CDC) during the 778:dengue flavivirus 375:Before cell entry 287: 286: 279: 261: 177:genetic sequences 16:(Redirected from 9314: 9274:Tropical disease 9210:Reverse zoonosis 9197:One Health Model 9026:Health education 9015:Community health 8934:Cordon sanitaire 8907:Ring vaccination 8877:Repurposed drugs 8764: 8763: 8683:Gastrointestinal 8526:Machine learning 8330:Gastrointestinal 8281:Intravenous line 8218: 8217: 8132:/Cross-infection 8119:Reverse zoonosis 8092: 8091: 8049: 8048: 7954: 7953: 7935:War and conflict 7803:Nutrition status 7766:Immunodeficiency 7623: 7622: 7599: 7592: 7585: 7576: 7575: 7335: 7334: 7331:Multiple/general 6902: 6901: 6866: 6859: 6852: 6843: 6842: 6769:Multiple/unknown 6722: 6721: 6718:Multiple/general 6488:Not TK activated 6340: 6339: 6330: 6329: 6321: 6320: 6312: 6311: 6276: 6269: 6262: 6253: 6252: 6067:Hydroxycarbamide 5934: 5933: 5728:Doravirine (DOR) 5716:Etravirine (ETR) 5711:Dapivirine (DPV) 5683:Nevirapine (NVP) 5668: 5667: 5573:Lamivudine (3TC) 5563:Didanosine (ddI) 5534: 5533: 5507:Tipranavir (TPV) 5495:Atazanavir (ATV) 5479:Saquinavir (SQV) 5469:Nelfinavir (NFV) 5449:Amprenavir (APV) 5439: 5438: 5321:Ibalizumab (IBA) 5216: 5209: 5202: 5193: 5192: 5178: 5157: 5156: 5141:Senotherapeutics 4995:Neuroprotectives 4990:Mood stabilizers 4889:Anti-ADHD agents 4829:Muscle relaxants 4762:Immunostimulants 4757:Immunomodulators 4589:Thyroid hormones 4527:Fertility agents 4430:Renin inhibitors 4321:Antihemorrhagics 4288:forming organs ( 4274:Dietary minerals 4180: 4173: 4166: 4157: 4156: 4150: 4149: 4147: 4145: 4131: 4125: 4124: 4122: 4120: 4106: 4100: 4099: 4087: 4081: 4080: 4072: 4066: 4065: 4063: 4061: 4055: 4048: 4039: 4030: 4029: 4019: 4009: 3977: 3971: 3970: 3960: 3950: 3926: 3920: 3919: 3891: 3885: 3884: 3863: 3854: 3853: 3852:(24): 2584–2593. 3840:December 2012). 3836: 3830: 3829: 3827: 3817: 3793: 3787: 3786: 3784: 3759: 3753: 3752: 3750: 3740: 3716: 3710: 3709: 3702: 3696: 3695: 3685: 3674:10.7326/M16-2575 3653: 3647: 3646: 3636: 3626: 3602: 3596: 3595: 3588: 3579: 3578: 3568: 3536: 3530: 3529: 3511: 3487: 3481: 3480: 3470: 3438: 3429: 3428: 3418: 3394: 3388: 3387: 3377: 3345: 3339: 3338: 3328: 3319:(4): 389. 2018. 3305: 3299: 3298: 3288: 3271:(1682): 809–17. 3256: 3250: 3249: 3247: 3245: 3230: 3221: 3220: 3218: 3216: 3202: 3193: 3192: 3187:. Archived from 3177: 3171: 3170: 3136: 3130: 3129: 3093: 3087: 3086: 3084: 3082: 3069: 3045: 3039: 3038: 3028: 3011:(7159): 660–62. 2996: 2985: 2984: 2973: 2952: 2951: 2949: 2947: 2938:. Archived from 2899: 2893: 2892: 2856: 2850: 2849: 2818:Semin. Liver Dis 2813: 2807: 2806: 2796: 2764: 2758: 2757: 2747: 2712: 2706: 2705: 2695: 2685: 2653: 2647: 2646: 2617: 2611: 2610: 2600: 2576: 2570: 2569: 2559: 2527: 2521: 2520: 2510: 2476: 2470: 2469: 2451: 2427: 2421: 2420: 2392: 2386: 2385: 2375: 2351: 2345: 2344: 2334: 2302: 2296: 2295: 2277: 2253: 2247: 2246: 2236: 2204: 2198: 2197: 2187: 2170:(8): 4599–4609. 2155: 2149: 2148: 2120: 2114: 2113: 2105: 2099: 2098: 2096: 2094: 2085:. Archived from 2079: 2073: 2072: 2064: 2058: 2057: 2047: 2030:(9): 2109–2115. 2015: 2009: 2008: 1990: 1984: 1983: 1973: 1941: 1935: 1934: 1898: 1892: 1891: 1858: 1852: 1851: 1841: 1809: 1803: 1802: 1800: 1798: 1787: 1781: 1780: 1770: 1753:(9): 1604–1613. 1738: 1732: 1731: 1721: 1703: 1679: 1670: 1669: 1620: 1614: 1613: 1581: 1575: 1574: 1572: 1538: 1529: 1528: 1518: 1508: 1484: 1478: 1477: 1467: 1435: 1429: 1428: 1408: 1402: 1401: 1391: 1381: 1349: 1343: 1342: 1334: 1328: 1327: 1317: 1307: 1283: 1277: 1276: 1265:Antiviral Agents 1261: 1193: 1188: 1187: 1141:chemoprophylaxis 1123:Furthermore, in 282: 275: 271: 268: 262: 260: 226:"Antiviral drug" 219: 195: 187: 63:viral infections 21: 9322: 9321: 9317: 9316: 9315: 9313: 9312: 9311: 9302:Antiviral drugs 9292: 9291: 9290: 9285: 9229: 9142:Antigenic shift 9137:Antigenic drift 9128: 9117: 8981:Barrier nursing 8929:Contact tracing 8920: 8913: 8758: 8756: 8749: 8660: 8650: 8551: 8545: 8536:Serial interval 8455: 8439: 8430:Cervico-vaginal 8425: 8416:Trans-placental 8411: 8395: 8363: 8325: 8261:Vascular system 8260: 8254: 8209: 8197: 8191: 8131: 8123: 8083: 8040: 7958: 7939: 7830: 7761:Immune response 7727: 7706:Drug resistance 7650:Infectious dose 7614: 7603: 7573: 7568: 7567: 7552:Clinical trials 7527: 7496: 7415: 7361: 7326: 7236: 7212: 7190: 7144: 7062: 6993: 6891: 6870: 6840: 6835: 6834: 6819:Clinical trials 6794: 6764: 6741: 6713: 6633: 6610: 6586: 6582:Podophyllotoxin 6551: 6499: 6479: 6399: 6344:Purine analogue 6325: 6301: 6280: 6250: 6245: 6244: 6232: 6217:Clinical trials 6192: 6143:Dexelvucitabine 6111: 6102:Tre recombinase 6005: 5987: 5969: 5965:Tat antagonists 5951: 5925: 5904: 5737: 5692: 5678:Efavirenz (EFV) 5657: 5649: 5578:Stavudine (d4T) 5539: 5527: 5516: 5501:Darunavir (DRV) 5483: 5474:Ritonavir (RTV) 5464:Lopinavir (LPV) 5459:Indinavir (IDV) 5428: 5420: 5392: 5350: 5342: 5296:Maraviroc (MVC) 5264: 5256: 5238: 5223:Antiviral drugs 5220: 5190: 5185: 5181:Medicine portal 5145: 5101: 5073: 5068: 5060:Cough medicines 5055:Bronchodilators 5036: 5029: 4909:Antidepressants 4899:Anticonvulsants 4847: 4838: 4834:Bisphosphonates 4824:Corticosteroids 4786: 4773: 4745: 4736: 4720:Spindle poisons 4710:Antimetabolites 4693: 4684: 4606: 4597: 4572:Glucocorticoids 4567:Corticosteroids 4548: 4541: 4508: 4501: 4458: 4376:Antiarrhythmics 4349: 4342: 4299:Antithrombotics 4287: 4278: 4254:Antipropulsives 4250:Antidiarrhoeals 4227: 4198: 4190: 4184: 4154: 4153: 4143: 4141: 4133: 4132: 4128: 4118: 4116: 4108: 4107: 4103: 4088: 4084: 4073: 4069: 4059: 4057: 4053: 4046: 4040: 4033: 3992:(3): e0121952. 3978: 3974: 3927: 3923: 3892: 3888: 3864: 3857: 3837: 3833: 3794: 3790: 3760: 3756: 3717: 3713: 3704: 3703: 3699: 3654: 3650: 3603: 3599: 3590: 3589: 3582: 3537: 3533: 3488: 3484: 3447:Virus Evolution 3439: 3432: 3395: 3391: 3346: 3342: 3307: 3306: 3302: 3265:Proc. Biol. Sci 3257: 3253: 3243: 3241: 3231: 3224: 3214: 3212: 3203: 3196: 3179: 3178: 3174: 3159: 3137: 3133: 3094: 3090: 3080: 3078: 3046: 3042: 2997: 2988: 2975: 2974: 2955: 2945: 2943: 2914:(11): 1815–22. 2900: 2896: 2857: 2853: 2814: 2810: 2765: 2761: 2713: 2709: 2654: 2650: 2618: 2614: 2577: 2573: 2528: 2524: 2499: 2477: 2473: 2428: 2424: 2393: 2389: 2352: 2348: 2317:(11): 5891–99. 2303: 2299: 2254: 2250: 2205: 2201: 2156: 2152: 2121: 2117: 2106: 2102: 2092: 2090: 2081: 2080: 2076: 2065: 2061: 2016: 2012: 2005: 1991: 1987: 1942: 1938: 1899: 1895: 1881: 1859: 1855: 1810: 1806: 1796: 1794: 1789: 1788: 1784: 1739: 1735: 1680: 1673: 1621: 1617: 1596:(68): 165–174. 1582: 1578: 1561: 1539: 1532: 1485: 1481: 1436: 1432: 1409: 1405: 1364:(13): 8013–18. 1350: 1346: 1335: 1331: 1284: 1280: 1263: 1262: 1258: 1253: 1231:Antiprion drugs 1189: 1182: 1179: 1155: 1149: 1120: 1115: 1107:interferon alfa 1095:cytomegalovirus 1005:antiviral drugs 997: 984: 970: 937: 920:(Relenza), and 883: 856: 854:immunostimulant 850: 830: 819: 744: 732:Lentinus edodes 713: 705: 685: 661:West Nile virus 638:cytomegalovirus 629: 613: 589: 536: 528: 454: 422: 420:Entry inhibitor 416: 414:Entry inhibitor 377: 319: 292: 283: 272: 266: 263: 220: 218: 208: 196: 185: 165:trial-and-error 118: 57:are a class of 55:Antiviral drugs 42: 35: 28: 23: 22: 15: 12: 11: 5: 9320: 9310: 9309: 9304: 9287: 9286: 9284: 9283: 9282: 9281: 9271: 9266: 9261: 9256: 9251: 9248: 9243: 9237: 9235: 9231: 9230: 9228: 9227: 9222: 9217: 9212: 9207: 9204: 9199: 9194: 9189: 9184: 9179: 9174: 9172:Emergent virus 9169: 9164: 9159: 9154: 9153: 9152: 9144: 9139: 9133: 9131: 9123: 9122: 9119: 9118: 9116: 9115: 9112: 9107: 9105:Vector control 9102: 9097: 9092: 9087: 9082: 9077: 9072: 9067: 9062: 9061: 9060: 9055: 9050: 9048:N95 respirator 9040: 9035: 9030: 9029: 9028: 9023: 9018: 9007: 9002: 9001: 9000: 8990: 8985: 8984: 8983: 8973: 8972: 8971: 8966: 8961: 8951: 8946: 8941: 8936: 8931: 8925: 8923: 8921:pharmaceutical 8915: 8914: 8912: 8911: 8910: 8909: 8904: 8899: 8894: 8889: 8879: 8874: 8869: 8864: 8859: 8854: 8853: 8852: 8842: 8837: 8832: 8827: 8822: 8817: 8812: 8811: 8810: 8800: 8799: 8798: 8788: 8783: 8782: 8781: 8770: 8768: 8767:Pharmaceutical 8761: 8751: 8750: 8748: 8747: 8744: 8739: 8734: 8729: 8724: 8719: 8718:Cardiovascular 8716: 8711: 8706: 8703: 8698: 8697:Nervous system 8695: 8692: 8691: 8690: 8680: 8679: 8678: 8673: 8664: 8662: 8656: 8655: 8652: 8651: 8649: 8648: 8643: 8638: 8633: 8628: 8623: 8618: 8613: 8608: 8603: 8598: 8593: 8588: 8583: 8582: 8581: 8576: 8566: 8561: 8555: 8553: 8547: 8546: 8544: 8543: 8538: 8533: 8528: 8523: 8521:Infection rate 8518: 8513: 8508: 8503: 8498: 8493: 8488: 8483: 8477: 8475: 8469: 8468: 8465: 8464: 8461: 8460: 8457: 8456: 8454: 8453: 8447: 8445: 8441: 8440: 8438: 8437: 8433: 8431: 8427: 8426: 8424: 8423: 8419: 8417: 8413: 8412: 8410: 8409: 8403: 8401: 8397: 8396: 8394: 8393: 8387: 8382: 8377: 8371: 8369: 8365: 8364: 8362: 8361: 8356: 8351: 8346: 8345: 8344: 8333: 8331: 8327: 8326: 8324: 8323: 8322: 8321: 8316: 8308: 8307: 8306: 8301: 8293: 8292: 8291: 8286: 8283: 8278: 8276:Injection site 8270: 8264: 8262: 8256: 8255: 8253: 8252: 8247: 8245:Dental aerosol 8242: 8241: 8240: 8230: 8224: 8222: 8215: 8211: 8210: 8208: 8207: 8201: 8199: 8193: 8192: 8190: 8189: 8184: 8183: 8182: 8177: 8176: 8175: 8170: 8167: 8156: 8155: 8154: 8149: 8141: 8135: 8133: 8129:Human-to-human 8125: 8124: 8122: 8121: 8116: 8111: 8106: 8100: 8098: 8089: 8085: 8084: 8082: 8081: 8075: 8072: 8069: 8064: 8059: 8055: 8053: 8046: 8042: 8041: 8039: 8038: 8033: 8028: 8026:Super-spreader 8023: 8021:Superinfection 8018: 8013: 8008: 8003: 7998: 7993: 7988: 7983: 7978: 7973: 7968: 7962: 7960: 7951: 7945: 7944: 7941: 7940: 7938: 7937: 7932: 7930:Vector control 7927: 7922: 7917: 7912: 7907: 7906: 7905: 7897: 7892: 7887: 7882: 7877: 7872: 7871: 7870: 7865: 7859:Climate zones 7857: 7855:Climate change 7852: 7849: 7846: 7840: 7838: 7832: 7831: 7829: 7828: 7827: 7826: 7823: 7820: 7819: 7818: 7810: 7807: 7804: 7801: 7798: 7790: 7785: 7780: 7775: 7774: 7773: 7768: 7758: 7753: 7748: 7743: 7737: 7735: 7729: 7728: 7726: 7725: 7720: 7719: 7718: 7713: 7708: 7698: 7697: 7696: 7691: 7686: 7681: 7671: 7669:Quorum sensing 7666: 7665: 7664: 7654: 7653: 7652: 7642: 7637: 7631: 7629: 7620: 7616: 7615: 7602: 7601: 7594: 7587: 7579: 7570: 7569: 7566: 7565: 7564: 7563: 7560: 7549: 7543: 7537: 7536: 7533: 7532: 7529: 7528: 7526: 7525: 7520: 7515: 7510: 7504: 7502: 7498: 7497: 7495: 7494: 7492:Valopicitabine 7489: 7484: 7479: 7474: 7469: 7464: 7459: 7454: 7449: 7444: 7439: 7434: 7429: 7423: 7421: 7417: 7416: 7414: 7413: 7403: 7398: 7388: 7383: 7378: 7372: 7370: 7363: 7362: 7360: 7359: 7354: 7349: 7343: 7341: 7332: 7328: 7327: 7325: 7324: 7314: 7309: 7293: 7292: 7286: 7281: 7265: 7264: 7259: 7254: 7248: 7246: 7238: 7237: 7235: 7234: 7222: 7220: 7214: 7213: 7211: 7210: 7204: 7202: 7196: 7195: 7192: 7191: 7189: 7188: 7183: 7178: 7173: 7168: 7163: 7158: 7152: 7150: 7146: 7145: 7143: 7142: 7137: 7132: 7127: 7122: 7117: 7112: 7107: 7102: 7097: 7092: 7087: 7082: 7076: 7074: 7071:RNA polymerase 7064: 7063: 7061: 7060: 7055: 7050: 7045: 7040: 7035: 7030: 7025: 7020: 7015: 7010: 7004: 7002: 6995: 6994: 6992: 6991: 6986: 6981: 6976: 6971: 6966: 6961: 6956: 6951: 6946: 6941: 6936: 6931: 6926: 6921: 6915: 6913: 6899: 6893: 6892: 6869: 6868: 6861: 6854: 6846: 6837: 6836: 6833: 6832: 6831: 6830: 6827: 6816: 6810: 6804: 6803: 6800: 6799: 6796: 6795: 6793: 6792: 6787: 6778: 6772: 6770: 6766: 6765: 6763: 6762: 6757: 6751: 6749: 6743: 6742: 6740: 6739: 6734: 6728: 6726: 6719: 6715: 6714: 6712: 6711: 6706: 6701: 6685: 6684: 6679: 6674: 6669: 6664: 6648: 6646: 6639: 6638: 6635: 6634: 6632: 6631: 6626: 6620: 6618: 6612: 6611: 6609: 6608: 6596: 6594: 6588: 6587: 6585: 6584: 6579: 6569: 6567: 6557: 6556: 6553: 6552: 6550: 6549: 6544: 6532: 6527: 6522: 6517: 6511: 6509: 6505: 6504: 6501: 6500: 6498: 6497: 6491: 6489: 6485: 6484: 6481: 6480: 6478: 6477: 6464: 6463: 6462: 6461: 6456: 6451: 6438: 6437: 6431: 6421: 6409: 6407: 6401: 6400: 6398: 6397: 6384: 6383: 6373: 6371:Valganciclovir 6364: 6348: 6346: 6337: 6327: 6318: 6309: 6303: 6302: 6279: 6278: 6271: 6264: 6256: 6247: 6246: 6231: 6230: 6229: 6228: 6225: 6214: 6208: 6202: 6201: 6198: 6197: 6194: 6193: 6191: 6190: 6185: 6180: 6175: 6170: 6165: 6160: 6155: 6150: 6145: 6140: 6135: 6130: 6125: 6119: 6117: 6113: 6112: 6110: 6109: 6104: 6099: 6094: 6089: 6084: 6079: 6074: 6069: 6064: 6059: 6054: 6049: 6044: 6039: 6034: 6029: 6024: 6019: 6013: 6011: 6007: 6006: 6004: 6003: 5997: 5995: 5989: 5988: 5986: 5985: 5979: 5977: 5971: 5970: 5968: 5967: 5961: 5959: 5953: 5952: 5950: 5949: 5942: 5940: 5931: 5927: 5926: 5924: 5923: 5918: 5916:Cobicistat (c) 5912: 5910: 5906: 5905: 5903: 5902: 5897: 5892: 5887: 5882: 5877: 5872: 5867: 5862: 5857: 5852: 5847: 5842: 5837: 5832: 5827: 5822: 5816: 5810: 5804: 5799: 5793: 5788: 5783: 5777: 5772: 5767: 5761: 5755: 5753: 5747: 5746: 5743: 5742: 5739: 5738: 5736: 5735: 5730: 5725: 5724: 5723: 5718: 5713: 5700: 5698: 5694: 5693: 5691: 5690: 5685: 5680: 5674: 5672: 5665: 5651: 5650: 5648: 5647: 5642: 5626: 5625: 5620: 5615: 5610: 5605: 5600: 5595: 5590: 5585: 5580: 5575: 5570: 5565: 5560: 5558:Abacavir (ABC) 5544: 5542: 5538:Nucleoside and 5531: 5522: 5521: 5518: 5517: 5515: 5514: 5509: 5504: 5498: 5491: 5489: 5485: 5484: 5482: 5481: 5476: 5471: 5466: 5461: 5456: 5451: 5445: 5443: 5436: 5422: 5421: 5419: 5418: 5413: 5408: 5402: 5400: 5394: 5393: 5391: 5390: 5385: 5380: 5375: 5370: 5365: 5360: 5354: 5352: 5344: 5343: 5341: 5340: 5328: 5312: 5298: 5287: 5274: 5272: 5258: 5257: 5255: 5254: 5248: 5246: 5240: 5239: 5219: 5218: 5211: 5204: 5196: 5187: 5186: 5184: 5183: 5172: 5167: 5162: 5150: 5147: 5146: 5144: 5143: 5138: 5133: 5128: 5126:Contrast media 5123: 5117: 5115: 5103: 5102: 5100: 5099: 5094: 5088: 5086: 5079:sensory organs 5075: 5074: 5072: 5071: 5066: 5062: 5057: 5052: 5046: 5044: 5031: 5030: 5028: 5027: 5022: 5017: 5012: 5007: 5002: 4997: 4992: 4987: 4978: 4977: 4976: 4971: 4966: 4956: 4951: 4946: 4941: 4936: 4931: 4926: 4924:Antipsychotics 4921: 4916: 4911: 4906: 4901: 4896: 4894:Antiaddictives 4891: 4886: 4881: 4880: 4879: 4874: 4864: 4858: 4856: 4849:nervous system 4840: 4839: 4837: 4836: 4831: 4826: 4821: 4819:Antirheumatics 4816: 4815: 4814: 4804: 4798: 4796: 4775: 4774: 4772: 4771: 4770: 4769: 4764: 4753: 4751: 4738: 4737: 4735: 4734: 4733: 4732: 4727: 4725:Antineoplastic 4722: 4717: 4712: 4701: 4699: 4686: 4685: 4683: 4682: 4677: 4672: 4671: 4670: 4665: 4660: 4658:Antiprotozoals 4653:Antiparasitics 4650: 4645: 4640: 4633:Antibacterials 4629:Antimicrobials 4625: 4623: 4599: 4598: 4596: 4595: 4586: 4581: 4580: 4579: 4574: 4564: 4558: 4556: 4543: 4542: 4540: 4539: 4534: 4529: 4524: 4518: 4516: 4503: 4502: 4500: 4499: 4494: 4492:Antipsoriatics 4489: 4484: 4479: 4473: 4471: 4460: 4459: 4457: 4456: 4455: 4454: 4449: 4444: 4434: 4433: 4432: 4427: 4422: 4420:ACE inhibitors 4410: 4405: 4400: 4395: 4390: 4385: 4384: 4383: 4378: 4373: 4359: 4357: 4348:cardiovascular 4344: 4343: 4341: 4340: 4339: 4338: 4333: 4328: 4318: 4317: 4316: 4311: 4309:Anticoagulants 4306: 4295: 4293: 4280: 4279: 4277: 4276: 4271: 4266: 4261: 4256: 4247: 4242: 4237: 4236: 4235: 4230: 4225: 4221: 4210: 4208: 4192: 4191: 4183: 4182: 4175: 4168: 4160: 4152: 4151: 4126: 4101: 4082: 4067: 4031: 3972: 3921: 3886: 3875:(2): 487–497. 3855: 3831: 3808:(5): 730–740. 3788: 3754: 3711: 3697: 3668:(9): 637–648. 3648: 3617:(4): 1421–32. 3597: 3580: 3531: 3502:(10): 953–56. 3482: 3430: 3389: 3340: 3300: 3251: 3222: 3194: 3172: 3157: 3131: 3088: 3060:(6): 1086–93. 3040: 2986: 2953: 2894: 2851: 2808: 2779:(4): 778–809. 2759: 2730:(2): 1103–14. 2707: 2648: 2612: 2571: 2536:Toxicol Pathol 2522: 2497: 2471: 2422: 2387: 2346: 2297: 2248: 2219:(8): 5116–28. 2199: 2150: 2115: 2100: 2074: 2059: 2010: 2003: 1985: 1956:(5): 2572–77. 1936: 1893: 1879: 1853: 1804: 1782: 1733: 1671: 1615: 1576: 1559: 1530: 1479: 1430: 1403: 1344: 1329: 1278: 1255: 1254: 1252: 1249: 1248: 1247: 1242: 1237: 1228: 1223: 1218: 1213: 1207: 1202: 1195: 1194: 1191:Viruses portal 1178: 1175: 1151:Main article: 1148: 1145: 1135:caused by the 1119: 1116: 1114: 1111: 1059: 1058: 1052: 1046: 1040: 1034: 1007:used to treat 996: 993: 983: 980: 969: 966: 936: 933: 891:antimicrobials 882: 879: 852:Main article: 849: 846: 836:(Relenza) and 829: 826: 818: 815: 790:H1N1 influenza 743: 740: 712: 709: 704: 701: 684: 681: 680: 679: 674: 669: 664: 654: 628: 625: 612: 609: 588: 585: 535: 532: 527: 524: 490:conjunctivitis 472:works against 453: 450: 418:Main article: 415: 412: 407: 406: 399: 392:anti-idiotypic 376: 373: 372: 371: 368: 365: 362: 359: 318: 315: 291: 288: 285: 284: 267:September 2022 199: 197: 190: 184: 181: 161:herpes viruses 126:herpes viruses 117: 114: 75:antimicrobials 26: 9: 6: 4: 3: 2: 9319: 9308: 9305: 9303: 9300: 9299: 9297: 9280: 9277: 9276: 9275: 9272: 9270: 9267: 9265: 9262: 9260: 9257: 9255: 9252: 9249: 9247: 9244: 9242: 9239: 9238: 9236: 9232: 9226: 9223: 9221: 9218: 9216: 9213: 9211: 9208: 9205: 9203: 9200: 9198: 9195: 9193: 9190: 9188: 9185: 9183: 9180: 9178: 9175: 9173: 9170: 9168: 9165: 9163: 9160: 9158: 9155: 9151: 9148: 9147: 9145: 9143: 9140: 9138: 9135: 9134: 9132: 9130: 9124: 9113: 9111: 9108: 9106: 9103: 9101: 9098: 9096: 9093: 9091: 9088: 9086: 9085:Sterilization 9083: 9081: 9078: 9076: 9073: 9071: 9068: 9066: 9063: 9059: 9056: 9054: 9053:Surgical mask 9051: 9049: 9046: 9045: 9044: 9041: 9039: 9036: 9034: 9031: 9027: 9024: 9022: 9019: 9016: 9013: 9012: 9011: 9010:Public health 9008: 9006: 9003: 8999: 8996: 8995: 8994: 8991: 8989: 8986: 8982: 8979: 8978: 8977: 8974: 8970: 8967: 8965: 8962: 8960: 8957: 8956: 8955: 8952: 8950: 8947: 8945: 8942: 8940: 8937: 8935: 8932: 8930: 8927: 8926: 8924: 8922: 8916: 8908: 8905: 8903: 8900: 8898: 8895: 8893: 8890: 8888: 8885: 8884: 8883: 8880: 8878: 8875: 8873: 8870: 8868: 8865: 8863: 8862:Phage therapy 8860: 8858: 8855: 8851: 8848: 8847: 8846: 8845:Immunotherapy 8843: 8841: 8838: 8836: 8833: 8831: 8828: 8826: 8823: 8821: 8818: 8816: 8813: 8809: 8806: 8805: 8804: 8803:Antimicrobial 8801: 8797: 8794: 8793: 8792: 8789: 8787: 8784: 8780: 8777: 8776: 8775: 8772: 8771: 8769: 8765: 8762: 8760: 8752: 8745: 8743: 8740: 8738: 8735: 8733: 8730: 8728: 8725: 8723: 8720: 8717: 8715: 8712: 8710: 8707: 8704: 8702: 8699: 8696: 8694:Genitourinary 8693: 8689: 8686: 8685: 8684: 8681: 8677: 8674: 8672: 8669: 8668: 8666: 8665: 8663: 8657: 8647: 8644: 8642: 8639: 8637: 8634: 8632: 8629: 8627: 8624: 8622: 8619: 8617: 8614: 8612: 8609: 8607: 8604: 8602: 8599: 8597: 8594: 8592: 8589: 8587: 8584: 8580: 8577: 8575: 8572: 8571: 8570: 8567: 8565: 8562: 8560: 8557: 8556: 8554: 8552:in population 8548: 8542: 8539: 8537: 8534: 8532: 8529: 8527: 8524: 8522: 8519: 8517: 8516:Herd immunity 8514: 8512: 8509: 8507: 8504: 8502: 8499: 8497: 8494: 8492: 8489: 8487: 8484: 8482: 8479: 8478: 8476: 8474: 8470: 8452: 8449: 8448: 8446: 8442: 8435: 8434: 8432: 8428: 8421: 8420: 8418: 8414: 8408: 8405: 8404: 8402: 8400:Genitourinary 8398: 8392: 8388: 8386: 8383: 8381: 8378: 8376: 8373: 8372: 8370: 8366: 8360: 8357: 8355: 8352: 8350: 8347: 8343: 8342:Contamination 8340: 8339: 8338: 8335: 8334: 8332: 8328: 8320: 8317: 8315: 8312: 8311: 8310:Vector-borne 8309: 8305: 8302: 8300: 8297: 8296: 8294: 8290: 8287: 8284: 8282: 8279: 8277: 8274: 8273: 8271: 8269: 8266: 8265: 8263: 8257: 8251: 8248: 8246: 8243: 8239: 8236: 8235: 8234: 8231: 8229: 8226: 8225: 8223: 8219: 8216: 8212: 8206: 8203: 8202: 8200: 8194: 8188: 8185: 8181: 8178: 8174: 8171: 8168: 8165: 8164: 8163: 8160: 8159: 8157: 8153: 8150: 8148: 8145: 8144: 8142: 8140: 8137: 8136: 8134: 8130: 8126: 8120: 8117: 8115: 8112: 8110: 8107: 8105: 8102: 8101: 8099: 8097: 8096:Cross-species 8093: 8090: 8086: 8079: 8076: 8073: 8070: 8068: 8065: 8063: 8060: 8057: 8056: 8054: 8050: 8047: 8043: 8037: 8036:Window period 8034: 8032: 8029: 8027: 8024: 8022: 8019: 8017: 8014: 8012: 8009: 8007: 8004: 8002: 8001:Latent period 7999: 7997: 7994: 7992: 7989: 7987: 7984: 7982: 7979: 7977: 7974: 7972: 7969: 7967: 7964: 7963: 7961: 7955: 7952: 7950: 7946: 7936: 7933: 7931: 7928: 7926: 7923: 7921: 7918: 7916: 7913: 7911: 7908: 7904: 7901: 7900: 7898: 7896: 7893: 7891: 7888: 7886: 7883: 7881: 7880:Deforestation 7878: 7876: 7873: 7869: 7866: 7864: 7861: 7860: 7858: 7856: 7853: 7850: 7847: 7845: 7842: 7841: 7839: 7837: 7833: 7825:Stress levels 7824: 7821: 7817: 7814: 7813: 7811: 7808: 7805: 7802: 7799: 7796: 7795: 7794: 7791: 7789: 7786: 7784: 7781: 7779: 7776: 7772: 7769: 7767: 7764: 7763: 7762: 7759: 7757: 7754: 7752: 7749: 7747: 7744: 7742: 7739: 7738: 7736: 7734: 7730: 7724: 7721: 7717: 7714: 7712: 7709: 7707: 7704: 7703: 7702: 7699: 7695: 7692: 7690: 7687: 7685: 7682: 7680: 7677: 7676: 7675: 7672: 7670: 7667: 7663: 7660: 7659: 7658: 7657:Pathogenicity 7655: 7651: 7648: 7647: 7646: 7643: 7641: 7638: 7636: 7633: 7632: 7630: 7628: 7624: 7621: 7617: 7612: 7608: 7600: 7595: 7593: 7588: 7586: 7581: 7580: 7577: 7561: 7559: 7556: 7555: 7553: 7550: 7547: 7544: 7542: 7539: 7538: 7534: 7524: 7521: 7519: 7516: 7514: 7511: 7509: 7506: 7505: 7503: 7499: 7493: 7490: 7488: 7485: 7483: 7480: 7478: 7475: 7473: 7470: 7468: 7465: 7463: 7460: 7458: 7455: 7453: 7450: 7448: 7445: 7443: 7440: 7438: 7435: 7433: 7430: 7428: 7425: 7424: 7422: 7418: 7411: 7407: 7404: 7402: 7399: 7396: 7392: 7389: 7387: 7384: 7382: 7379: 7377: 7374: 7373: 7371: 7368: 7364: 7358: 7355: 7353: 7350: 7348: 7345: 7344: 7342: 7340: 7336: 7333: 7329: 7322: 7318: 7315: 7313: 7310: 7308: 7304: 7303: 7302:release phase 7299: 7295: 7294: 7290: 7287: 7285: 7282: 7280: 7276: 7275: 7274:M2 inhibitors 7271: 7267: 7266: 7263: 7260: 7258: 7255: 7253: 7250: 7249: 7247: 7244: 7239: 7233: 7230: 7228: 7224: 7223: 7221: 7219: 7215: 7209: 7206: 7205: 7203: 7201: 7197: 7187: 7184: 7182: 7179: 7177: 7174: 7172: 7169: 7167: 7164: 7162: 7159: 7157: 7154: 7153: 7151: 7147: 7141: 7138: 7136: 7133: 7131: 7128: 7126: 7123: 7121: 7118: 7116: 7113: 7111: 7108: 7106: 7103: 7101: 7098: 7096: 7093: 7091: 7088: 7086: 7085:Bemnifosbuvir 7083: 7081: 7078: 7077: 7075: 7072: 7069: 7065: 7059: 7056: 7054: 7051: 7049: 7046: 7044: 7041: 7039: 7036: 7034: 7031: 7029: 7026: 7024: 7021: 7019: 7016: 7014: 7011: 7009: 7006: 7005: 7003: 7000: 6996: 6990: 6987: 6985: 6982: 6980: 6977: 6975: 6972: 6970: 6967: 6965: 6962: 6960: 6957: 6955: 6952: 6950: 6947: 6945: 6942: 6940: 6937: 6935: 6932: 6930: 6927: 6925: 6922: 6920: 6917: 6916: 6914: 6911: 6907: 6903: 6900: 6898: 6894: 6889: 6885: 6881: 6877: 6874: 6867: 6862: 6860: 6855: 6853: 6848: 6847: 6844: 6828: 6826: 6823: 6822: 6820: 6817: 6814: 6811: 6809: 6806: 6805: 6801: 6791: 6788: 6786: 6782: 6779: 6777: 6774: 6773: 6771: 6767: 6761: 6758: 6756: 6753: 6752: 6750: 6748: 6744: 6738: 6737:Brincidofovir 6735: 6733: 6730: 6729: 6727: 6723: 6720: 6716: 6710: 6707: 6705: 6702: 6700: 6697: 6695: 6691: 6687: 6686: 6683: 6680: 6678: 6675: 6673: 6670: 6668: 6665: 6663: 6660: 6658: 6654: 6650: 6649: 6647: 6644: 6640: 6630: 6627: 6625: 6622: 6621: 6619: 6617: 6613: 6607: 6604: 6602: 6598: 6597: 6595: 6593: 6589: 6583: 6580: 6578: 6574: 6571: 6570: 6568: 6566: 6562: 6558: 6548: 6545: 6542: 6538: 6537: 6536:early protein 6533: 6531: 6528: 6526: 6523: 6521: 6518: 6516: 6513: 6512: 6510: 6506: 6496: 6493: 6492: 6490: 6486: 6475: 6471: 6470: 6466: 6465: 6460: 6457: 6455: 6452: 6450: 6447: 6446: 6445: 6444: 6440: 6439: 6435: 6432: 6429: 6425: 6422: 6420: 6416: 6415: 6411: 6410: 6408: 6406: 6402: 6395: 6391: 6390: 6386: 6385: 6381: 6377: 6374: 6372: 6368: 6365: 6363: 6359: 6355: 6354: 6350: 6349: 6347: 6345: 6341: 6338: 6335: 6331: 6328: 6324:DNA-synthesis 6322: 6319: 6317: 6313: 6310: 6308: 6304: 6299: 6295: 6291: 6287: 6284: 6277: 6272: 6270: 6265: 6263: 6258: 6257: 6254: 6242: 6239: 6236: 6226: 6224: 6221: 6220: 6218: 6215: 6212: 6209: 6207: 6204: 6203: 6199: 6189: 6186: 6184: 6181: 6179: 6176: 6174: 6171: 6169: 6166: 6164: 6161: 6159: 6156: 6154: 6151: 6149: 6146: 6144: 6141: 6139: 6136: 6134: 6131: 6129: 6126: 6124: 6121: 6120: 6118: 6116:Failed agents 6114: 6108: 6105: 6103: 6100: 6098: 6095: 6093: 6090: 6088: 6085: 6083: 6080: 6078: 6075: 6073: 6070: 6068: 6065: 6063: 6060: 6058: 6055: 6053: 6050: 6048: 6045: 6043: 6040: 6038: 6035: 6033: 6030: 6028: 6025: 6023: 6020: 6018: 6015: 6014: 6012: 6008: 6002: 5999: 5998: 5996: 5994: 5990: 5984: 5983:Trichosanthin 5981: 5980: 5978: 5976: 5972: 5966: 5963: 5962: 5960: 5958: 5954: 5947: 5944: 5943: 5941: 5939: 5935: 5932: 5928: 5922: 5921:Ritonavir (r) 5919: 5917: 5914: 5913: 5911: 5907: 5901: 5898: 5896: 5893: 5891: 5888: 5886: 5883: 5881: 5878: 5876: 5873: 5871: 5868: 5866: 5863: 5861: 5858: 5856: 5853: 5851: 5848: 5846: 5843: 5841: 5838: 5836: 5833: 5831: 5828: 5826: 5823: 5820: 5817: 5814: 5811: 5808: 5805: 5803: 5800: 5797: 5794: 5792: 5789: 5787: 5784: 5781: 5778: 5776: 5773: 5771: 5768: 5765: 5762: 5760: 5757: 5756: 5754: 5752: 5748: 5734: 5731: 5729: 5726: 5722: 5719: 5717: 5714: 5712: 5709: 5708: 5707: 5706: 5702: 5701: 5699: 5695: 5689: 5686: 5684: 5681: 5679: 5676: 5675: 5673: 5669: 5666: 5664: 5662: 5656: 5652: 5646: 5643: 5641: 5638: 5636: 5632: 5628: 5627: 5624: 5621: 5619: 5616: 5614: 5611: 5609: 5606: 5604: 5601: 5599: 5596: 5594: 5591: 5589: 5586: 5584: 5581: 5579: 5576: 5574: 5571: 5569: 5566: 5564: 5561: 5559: 5556: 5554: 5550: 5546: 5545: 5543: 5541: 5535: 5532: 5529: 5523: 5513: 5510: 5508: 5505: 5502: 5499: 5496: 5493: 5492: 5490: 5486: 5480: 5477: 5475: 5472: 5470: 5467: 5465: 5462: 5460: 5457: 5455: 5452: 5450: 5447: 5446: 5444: 5440: 5437: 5435: 5433: 5427: 5423: 5417: 5414: 5412: 5409: 5407: 5404: 5403: 5401: 5399: 5395: 5389: 5386: 5384: 5381: 5379: 5376: 5374: 5371: 5369: 5366: 5364: 5361: 5359: 5356: 5355: 5353: 5349: 5345: 5338: 5334: 5333: 5329: 5326: 5322: 5318: 5317: 5313: 5310: 5306: 5302: 5299: 5297: 5293: 5292: 5288: 5285: 5281: 5280: 5276: 5275: 5273: 5271: 5269: 5263: 5259: 5253: 5250: 5249: 5247: 5245: 5241: 5236: 5232: 5229:used against 5228: 5224: 5217: 5212: 5210: 5205: 5203: 5198: 5197: 5194: 5182: 5177: 5173: 5171: 5168: 5166: 5163: 5161: 5152: 5151: 5148: 5142: 5139: 5137: 5134: 5132: 5129: 5127: 5124: 5122: 5119: 5118: 5116: 5113: 5109: 5104: 5098: 5095: 5093: 5090: 5089: 5087: 5084: 5080: 5076: 5070: 5063: 5061: 5058: 5056: 5053: 5051: 5050:Decongestants 5048: 5047: 5045: 5042: 5038: 5032: 5026: 5023: 5021: 5018: 5016: 5013: 5011: 5008: 5006: 5003: 5001: 4998: 4996: 4993: 4991: 4988: 4986: 4982: 4979: 4975: 4972: 4970: 4969:Dissociatives 4967: 4965: 4962: 4961: 4960: 4959:Hallucinogens 4957: 4955: 4952: 4950: 4947: 4945: 4942: 4940: 4937: 4935: 4932: 4930: 4927: 4925: 4922: 4920: 4917: 4915: 4912: 4910: 4907: 4905: 4902: 4900: 4897: 4895: 4892: 4890: 4887: 4885: 4882: 4878: 4875: 4873: 4870: 4869: 4868: 4865: 4863: 4860: 4859: 4857: 4854: 4850: 4845: 4841: 4835: 4832: 4830: 4827: 4825: 4822: 4820: 4817: 4813: 4810: 4809: 4808: 4805: 4803: 4800: 4799: 4797: 4794: 4790: 4784: 4780: 4776: 4768: 4765: 4763: 4760: 4759: 4758: 4755: 4754: 4752: 4749: 4743: 4739: 4731: 4728: 4726: 4723: 4721: 4718: 4716: 4713: 4711: 4708: 4707: 4706: 4703: 4702: 4700: 4697: 4691: 4687: 4681: 4678: 4676: 4673: 4669: 4666: 4664: 4663:Anthelmintics 4661: 4659: 4656: 4655: 4654: 4651: 4649: 4646: 4644: 4641: 4638: 4634: 4630: 4627: 4626: 4624: 4621: 4617: 4613: 4609: 4604: 4600: 4594: 4590: 4587: 4585: 4582: 4578: 4575: 4573: 4570: 4569: 4568: 4565: 4563: 4560: 4559: 4557: 4554: 4550: 4544: 4538: 4535: 4533: 4530: 4528: 4525: 4523: 4520: 4519: 4517: 4514: 4510: 4507:genitourinary 4504: 4498: 4495: 4493: 4490: 4488: 4487:Antipruritics 4485: 4483: 4480: 4478: 4475: 4474: 4472: 4469: 4465: 4461: 4453: 4450: 4448: 4445: 4443: 4440: 4439: 4438: 4435: 4431: 4428: 4426: 4423: 4421: 4418: 4417: 4416: 4415: 4411: 4409: 4406: 4404: 4403:Beta blockers 4401: 4399: 4396: 4394: 4391: 4389: 4386: 4382: 4379: 4377: 4374: 4372: 4369: 4368: 4367: 4366: 4361: 4360: 4358: 4355: 4351: 4345: 4337: 4334: 4332: 4329: 4327: 4324: 4323: 4322: 4319: 4315: 4312: 4310: 4307: 4305: 4304:Antiplatelets 4302: 4301: 4300: 4297: 4296: 4294: 4291: 4285: 4281: 4275: 4272: 4270: 4267: 4265: 4262: 4260: 4257: 4255: 4251: 4248: 4246: 4243: 4241: 4238: 4234: 4231: 4229: 4222: 4220: 4217: 4216: 4215: 4212: 4211: 4209: 4206: 4202: 4197: 4193: 4189: 4181: 4176: 4174: 4169: 4167: 4162: 4161: 4158: 4140: 4136: 4130: 4115: 4111: 4105: 4097: 4093: 4086: 4078: 4071: 4052: 4045: 4038: 4036: 4027: 4023: 4018: 4013: 4008: 4003: 3999: 3995: 3991: 3987: 3983: 3976: 3968: 3964: 3959: 3954: 3949: 3944: 3940: 3936: 3932: 3925: 3917: 3913: 3909: 3905: 3901: 3897: 3890: 3882: 3878: 3874: 3870: 3862: 3860: 3851: 3847: 3843: 3835: 3826: 3821: 3816: 3811: 3807: 3803: 3799: 3792: 3783: 3778: 3774: 3770: 3766: 3758: 3749: 3744: 3739: 3734: 3730: 3726: 3722: 3715: 3707: 3701: 3693: 3689: 3684: 3679: 3675: 3671: 3667: 3663: 3659: 3652: 3644: 3640: 3635: 3630: 3625: 3620: 3616: 3612: 3608: 3601: 3593: 3587: 3585: 3576: 3572: 3567: 3562: 3558: 3554: 3551:(2): 413–37. 3550: 3546: 3542: 3535: 3527: 3523: 3519: 3515: 3510: 3505: 3501: 3497: 3493: 3486: 3478: 3474: 3469: 3464: 3460: 3456: 3453:(1): vew014. 3452: 3448: 3444: 3437: 3435: 3426: 3422: 3417: 3412: 3409:(3): 403–21. 3408: 3404: 3400: 3393: 3385: 3381: 3376: 3371: 3367: 3363: 3359: 3355: 3351: 3344: 3336: 3332: 3327: 3322: 3318: 3314: 3310: 3304: 3296: 3292: 3287: 3282: 3278: 3274: 3270: 3266: 3262: 3255: 3240: 3239:Virology Blog 3236: 3229: 3227: 3210: 3209: 3201: 3199: 3190: 3186: 3182: 3176: 3168: 3164: 3160: 3154: 3150: 3146: 3142: 3135: 3127: 3123: 3119: 3115: 3111: 3107: 3104:(6): 510–13. 3103: 3099: 3092: 3077: 3073: 3068: 3063: 3059: 3055: 3051: 3044: 3036: 3032: 3027: 3022: 3018: 3014: 3010: 3006: 3002: 2995: 2993: 2991: 2982: 2978: 2972: 2970: 2968: 2966: 2964: 2962: 2960: 2958: 2941: 2937: 2933: 2929: 2925: 2921: 2917: 2913: 2909: 2905: 2898: 2890: 2886: 2882: 2878: 2874: 2870: 2867:(6): 639–43. 2866: 2862: 2855: 2847: 2843: 2839: 2835: 2831: 2827: 2823: 2819: 2812: 2804: 2800: 2795: 2790: 2786: 2782: 2778: 2774: 2770: 2763: 2755: 2751: 2746: 2741: 2737: 2733: 2729: 2725: 2721: 2717: 2711: 2703: 2699: 2694: 2689: 2684: 2679: 2675: 2671: 2668:(7): e22572. 2667: 2663: 2659: 2652: 2644: 2640: 2636: 2632: 2629:(1): 367–73. 2628: 2624: 2616: 2608: 2604: 2599: 2594: 2591:(3): 915–23. 2590: 2586: 2582: 2575: 2567: 2563: 2558: 2553: 2549: 2545: 2541: 2537: 2533: 2526: 2518: 2514: 2509: 2504: 2500: 2494: 2490: 2486: 2482: 2475: 2467: 2463: 2459: 2455: 2450: 2445: 2442:(1): 207–11. 2441: 2437: 2433: 2426: 2418: 2414: 2410: 2406: 2403:(5): 385–99. 2402: 2398: 2391: 2383: 2379: 2374: 2369: 2366:(6): 538–44. 2365: 2361: 2357: 2350: 2342: 2338: 2333: 2328: 2324: 2320: 2316: 2312: 2308: 2301: 2293: 2289: 2285: 2281: 2276: 2271: 2268:(2): 503–08. 2267: 2263: 2259: 2252: 2244: 2240: 2235: 2230: 2226: 2222: 2218: 2214: 2210: 2203: 2195: 2191: 2186: 2181: 2177: 2173: 2169: 2165: 2161: 2154: 2146: 2142: 2138: 2134: 2131:(5): 317–25. 2130: 2126: 2119: 2111: 2104: 2088: 2084: 2078: 2070: 2063: 2055: 2051: 2046: 2041: 2037: 2033: 2029: 2025: 2021: 2014: 2006: 2000: 1996: 1989: 1981: 1977: 1972: 1967: 1963: 1959: 1955: 1951: 1947: 1940: 1932: 1928: 1924: 1920: 1916: 1912: 1909:(6): 261–71. 1908: 1904: 1903:Intervirology 1897: 1890: 1886: 1882: 1876: 1872: 1868: 1864: 1857: 1849: 1845: 1840: 1835: 1831: 1827: 1824:(3): 285–99. 1823: 1819: 1815: 1808: 1792: 1786: 1778: 1774: 1769: 1764: 1760: 1756: 1752: 1748: 1744: 1737: 1729: 1725: 1720: 1715: 1711: 1707: 1702: 1697: 1693: 1689: 1685: 1678: 1676: 1667: 1663: 1659: 1655: 1651: 1647: 1643: 1639: 1635: 1631: 1627: 1619: 1611: 1607: 1603: 1599: 1595: 1591: 1587: 1580: 1571: 1566: 1562: 1556: 1552: 1548: 1544: 1537: 1535: 1526: 1522: 1517: 1512: 1507: 1502: 1498: 1494: 1490: 1483: 1475: 1471: 1466: 1461: 1457: 1453: 1449: 1445: 1441: 1434: 1426: 1422: 1419:(4): 343–47. 1418: 1414: 1413:Die Pharmazie 1407: 1399: 1395: 1390: 1385: 1380: 1375: 1371: 1367: 1363: 1359: 1355: 1348: 1340: 1333: 1325: 1321: 1316: 1311: 1306: 1301: 1297: 1293: 1292:Antiviral Res 1289: 1282: 1274: 1270: 1266: 1260: 1256: 1246: 1243: 1241: 1238: 1236: 1232: 1229: 1227: 1224: 1222: 1219: 1217: 1214: 1211: 1208: 1206: 1203: 1200: 1197: 1196: 1192: 1186: 1181: 1174: 1171: 1167: 1163: 1159: 1154: 1144: 1142: 1138: 1134: 1130: 1126: 1113:Public policy 1110: 1108: 1104: 1100: 1096: 1092: 1088: 1084: 1079: 1077: 1072: 1068: 1064: 1056: 1053: 1050: 1047: 1044: 1041: 1038: 1035: 1032: 1029: 1028: 1027: 1024: 1022: 1018: 1014: 1010: 1006: 1002: 992: 988: 979: 976: 965: 961: 959: 955: 950: 946: 943: 932: 929: 928: 923: 919: 915: 910: 907: 903: 899: 894: 892: 887: 878: 876: 872: 867: 865: 860: 855: 845: 843: 842:neuraminidase 839: 835: 828:Release phase 825: 823: 814: 812: 808: 803: 799: 795: 791: 787: 783: 779: 775: 771: 767: 763: 762: 757: 753: 749: 739: 737: 733: 729: 724: 722: 718: 708: 700: 697: 692: 690: 678: 677:coronaviruses 675: 673: 670: 668: 665: 662: 658: 655: 653: 652:caliciviruses 650: 649: 648: 645: 643: 639: 635: 624: 622: 618: 617:messenger RNA 611:Transcription 608: 606: 602: 598: 594: 584: 582: 577: 575: 570: 568: 564: 559: 557: 553: 549: 545: 541: 531: 523: 520: 516: 512: 507: 505: 504: 497: 495: 491: 487: 483: 482:enteroviruses 479: 475: 471: 467: 465: 461: 457: 449: 445: 443: 437: 435: 431: 427: 421: 411: 404: 400: 397: 393: 389: 388: 387: 384: 382: 369: 366: 363: 360: 357: 356: 355: 352: 350: 345: 343: 339: 335: 331: 327: 324:consist of a 323: 314: 312: 308: 303: 301: 296: 281: 278: 270: 259: 256: 252: 249: 245: 242: 238: 235: 231: 228: â€“  227: 223: 222:Find sources: 216: 212: 206: 205: 200:This section 198: 194: 189: 188: 180: 178: 174: 169: 166: 162: 157: 155: 149: 145: 143: 139: 136:viruses, and 135: 131: 127: 123: 113: 111: 107: 103: 99: 96: 92: 88: 87:antiparasitic 84: 80: 76: 72: 68: 64: 60: 56: 48: 44: 40: 33: 19: 8993:Notification 8964:Hand washing 8959:Food hygiene 8944:Disinfection 8840:Immunization 8819: 8791:Anthelmintic 8779:prophylactic 8667:Respiratory 8591:Hyperendemic 8541:WAIFW matrix 8196:Environment- 7949:Transmission 7925:Urbanization 7723:Host tropism 7619:Determinants 7605:Concepts in 7467:Molnupiravir 7462:Mericitabine 7432:Deuremidevir 7406:Simnotrelvir 7391:Nirmatrelvir 7381:Ibuzatrelvir 7367:3CL protease 7296: 7268: 7225: 7218:Picornavirus 7140:Uprifosbuvir 7038:Pibrentasvir 6989:Voxilaprevir 6959:Paritaprevir 6875: 6776:Filociclovir 6688: 6651: 6599: 6547:Tromantadine 6534: 6467: 6441: 6424:Trifluridine 6412: 6387: 6362:Valaciclovir 6351: 6285: 6237: 6037:Cyanovirin-N 6027:Calanolide A 5703: 5697:2 generation 5671:1 generation 5658: 5629: 5608:Elvucitabine 5598:Apricitabine 5547: 5488:2 generation 5442:1 generation 5429: 5416:Fipravirimat 5330: 5325:Semzuvolimab 5314: 5305:Cenicriviroc 5289: 5277: 5265: 5222: 4964:Psychedelics 4934:Aphrodisiacs 4647: 4608:infestations 4584:Sex hormones 4537:Sex hormones 4482:Cicatrizants 4412: 4398:Vasodilators 4365:antianginals 4362: 4214:stomach acid 4213: 4142:. Retrieved 4138: 4129: 4117:. Retrieved 4113: 4104: 4095: 4085: 4070: 4058:. Retrieved 4051:the original 3989: 3985: 3975: 3938: 3934: 3924: 3899: 3895: 3889: 3872: 3868: 3849: 3845: 3834: 3805: 3801: 3791: 3775:(1): 41–45. 3772: 3768: 3757: 3728: 3724: 3714: 3700: 3665: 3661: 3651: 3614: 3610: 3600: 3548: 3544: 3534: 3499: 3495: 3485: 3450: 3446: 3406: 3402: 3392: 3357: 3353: 3343: 3316: 3312: 3303: 3268: 3264: 3254: 3242:. Retrieved 3238: 3213:. Retrieved 3207: 3189:the original 3184: 3175: 3140: 3134: 3101: 3097: 3091: 3079:. Retrieved 3057: 3053: 3043: 3008: 3004: 2980: 2944:. Retrieved 2940:the original 2911: 2907: 2897: 2864: 2860: 2854: 2824:(1): 53–65. 2821: 2817: 2811: 2776: 2772: 2762: 2727: 2723: 2710: 2665: 2661: 2651: 2626: 2622: 2615: 2588: 2584: 2574: 2542:(1): 65–77. 2539: 2535: 2525: 2480: 2474: 2439: 2435: 2425: 2400: 2396: 2390: 2363: 2359: 2349: 2314: 2310: 2300: 2265: 2261: 2251: 2216: 2212: 2202: 2167: 2163: 2153: 2128: 2124: 2118: 2103: 2091:. Retrieved 2087:the original 2077: 2062: 2027: 2023: 2013: 1994: 1988: 1953: 1949: 1939: 1906: 1902: 1896: 1862: 1856: 1821: 1817: 1807: 1795:. Retrieved 1785: 1750: 1746: 1736: 1691: 1687: 1633: 1629: 1618: 1593: 1589: 1579: 1542: 1496: 1492: 1482: 1447: 1443: 1433: 1416: 1412: 1406: 1361: 1357: 1347: 1338: 1332: 1295: 1291: 1281: 1264: 1259: 1205:CRISPR-Cas13 1156: 1121: 1080: 1060: 1025: 1004: 1000: 998: 989: 985: 971: 962: 958:reassortment 951: 947: 938: 925: 911: 895: 884: 868: 861: 857: 831: 820: 797: 770:oligomerizer 759: 745: 735: 731: 725: 714: 706: 693: 686: 657:flaviviruses 646: 630: 614: 605:dolutegravir 601:elvitegravir 590: 578: 571: 560: 537: 529: 519:adenoviruses 508: 501: 498: 494:encephalitis 474:rhinoviruses 468: 458: 455: 446: 438: 423: 408: 385: 378: 353: 346: 320: 304: 297: 293: 273: 264: 254: 247: 240: 233: 221: 209:Please help 204:verification 201: 173:side effects 170: 158: 150: 146: 119: 116:Medical uses 54: 53: 43: 9246:Eradication 9157:Biosecurity 8882:Vaccination 8857:Inoculation 8835:Drug safety 8830:Combination 8757:and Control 8705:Soft tissue 8659:Anatomical 8626:Seasonality 8606:Mesoendemic 8586:Holoendemic 8579:Farr's laws 8491:Attack rate 8289:Animal bite 8285:Insect bite 8221:Respiratory 7848:Air quality 7836:Environment 7746:Comorbidity 7662:Attack rate 7645:Infectivity 7548:from market 7513:Merimepodib 7487:Triazavirin 7482:Taribavirin 7442:Galidesivir 7437:Favipiravir 7401:Rupintrivir 7386:Lufotrelvir 7376:Ensitrelvir 7321:Laninamivir 7307:Oseltamivir 7289:Rimantadine 7227:viral entry 7208:Bulevirtide 7200:Hepatitis D 7058:Velpatasvir 7013:Daclatasvir 7008:Coblopasvir 6984:Vedroprevir 6954:Narlaprevir 6949:Grazoprevir 6944:Glecaprevir 6939:Faldaprevir 6919:Asunaprevir 6897:Hepatitis C 6878:(primarily 6815:from market 6785:Taribavirin 6677:Telbivudine 6643:Hepatitis B 6629:Tecovirimat 6624:Methisazone 6419:Idoxuridine 6380:Famciclovir 6376:Penciclovir 6367:Ganciclovir 6316:Herpesvirus 6307:Baltimore I 6288:(primarily 6238:recommended 6213:from market 6163:Lersivirine 6138:Capravirine 6077:Miltefosine 6062:Griffithsin 6057:Fosdevirine 5603:Censavudine 5233:(primarily 5097:Otologicals 5069:antagonists 5035:respiratory 5010:Orexigenics 5005:Neurotoxins 4954:Euphoriants 4944:Entactogens 4939:Depressants 4929:Anxiolytics 4867:Anesthetics 4643:Antifungals 4240:Antiemetics 4228:antagonists 3360:(1): 6–10. 3185:www.who.int 1147:Stockpiling 1009:hepatitis C 916:(Tamiflu), 914:oseltamivir 906:influenza B 902:influenza A 864:interferons 838:oseltamivir 807:procaspases 696:hepatitis C 659:(including 644:antisense. 597:raltegravir 478:common cold 464:rimantadine 442:Enfuvirtide 426:viral entry 138:influenza A 130:hepatitis B 9296:Categories 9129:infections 9070:Sanitation 9038:Quarantine 8897:resistance 8815:Antiseptic 8796:Ascaricide 8786:Antifungal 8774:Antibiotic 8755:Prevention 8688:Intestinal 8621:Prevalence 8601:Inequality 8550:Occurrence 8349:Breastmilk 8233:Bioaerosol 8205:Sapronosis 8180:Horizontal 8052:Endogenous 8031:Viral load 7991:Index case 7523:Presatovir 7518:Moroxydine 7452:Remdesivir 7410:+ritonavir 7395:+ritonavir 7339:Interferon 7284:Amantadine 7279:Adapromine 7262:Umifenovir 7232:Pleconaril 7135:Radalbuvir 7130:TMC-647055 7120:Sofosbuvir 7115:Setrobuvir 7095:Deleobuvir 7080:Beclabuvir 7053:Samatasvir 7043:Ravidasvir 7033:Ombitasvir 7023:Ledipasvir 6979:Vaniprevir 6974:Telaprevir 6969:Sovaprevir 6964:Simeprevir 6934:Danoprevir 6929:Ciluprevir 6924:Boceprevir 6876:antivirals 6790:Moroxydine 6747:Interferon 6667:Lamivudine 6616:Poxviridae 6606:Rifampicin 6577:Resiquimod 6541:Fomivirsen 6525:Letermovir 6515:Amenamevir 6474:Cytarabine 6459:Sorivudine 6428:+tipiracil 6394:Vidarabine 6286:antivirals 6168:Lodenosine 6148:Droxinavir 6133:Brecanavir 6128:Atevirdine 6092:Seliciclib 6087:Scytovirin 6001:Elipovimab 5946:TRIM5alpha 5623:Stampidine 5528:inhibitors 5512:TMC-310911 5411:BMS-955176 5309:Leronlimab 5301:Vicriviroc 5020:Stimulants 5000:Nootropics 4974:Deliriants 4949:Entheogens 4884:Anorectics 4862:Analgesics 4715:Alkylating 4648:Antivirals 4603:infections 4477:Emollients 4331:Coagulants 4201:metabolism 4144:21 October 4119:21 October 4077:"H1N1 Flu" 4060:21 October 3869:Hepatology 3769:Hepatology 3244:1 December 3215:1 December 3081:30 October 2946:31 October 2262:Hepatology 1694:(3): 850. 1499:(4): 810. 1298:: 94–103. 1251:References 1235:Astemizole 1137:H1N1 virus 1091:letermovir 1017:interferon 871:antibodies 822:Rifampicin 794:rhinovirus 786:bunyavirus 782:arenavirus 756:base pairs 730:mushroom ( 642:morpholino 634:fomivirsen 574:lamivudine 567:zidovudine 544:nucleoside 540:nucleotide 486:meningitis 470:Pleconaril 460:Amantadine 403:antibodies 336:(called a 237:newspapers 106:eucalyptus 98:infections 83:antifungal 79:antibiotic 69:, while a 59:medication 9241:Discovery 9167:Disease X 9127:Emerging 9075:Screening 8976:Isolation 8820:Antiviral 8646:Twindemic 8596:Incidence 8473:Modelling 8436:Perinatal 8368:Cutaneous 8259:Linked to 8169:Perinatal 8088:Exogenous 8080:formation 7822:Pregnancy 7679:Endotoxin 7674:Virulence 7558:Phase III 7546:Withdrawn 7477:Ribavirin 7447:GS-441524 7317:Peramivir 7312:Zanamivir 7257:Pimodivir 7243:influenza 7125:Tegobuvir 7100:Filibuvir 7090:Dasabuvir 7028:Odalasvir 6873:RNA virus 6825:Phase III 6813:Withdrawn 6781:Ribavirin 6732:Cidofovir 6682:Clevudine 6672:Lobucavir 6662:Entecavir 6573:Imiquimod 6530:Maribavir 6520:Docosanol 6495:Foscarnet 6449:Brivudine 6434:Edoxudine 6358:Aciclovir 6336:activated 6326:inhibitor 6283:DNA virus 6223:Phase III 6211:Withdrawn 6188:Telinavir 6183:Palinavir 6178:Mozenavir 6158:Emivirine 6153:Lasinavir 6123:Aplaviroc 6052:Foscarnet 6032:Ceragenin 5593:Amdoxovir 5406:Bevirimat 5383:BI 224436 5170:ATC codes 5136:Dressings 5121:Antidotes 4985:Sedatives 4981:Hypnotics 4690:malignant 4547:endocrine 4393:Diuretics 4326:Platelets 4286:and blood 4245:Laxatives 3941:(1): 32. 3526:205104988 2846:260319327 2436:FEBS Lett 2093:8 January 1889:181538245 1797:7 January 1710:1420-3049 1688:Molecules 1666:143434120 1650:0022-2623 1610:1665-5796 1212:(for HIV) 1101:(against 1093:(against 1085:(against 1083:aciclovir 1021:genotypes 1013:ribavirin 999:The term 987:viruses. 942:pneumonia 922:peramivir 918:zanamivir 834:zanamivir 802:apoptosis 752:mammalian 689:ribozymes 593:integrase 587:Integrase 563:aciclovir 506:in 2016. 302:program. 144:viruses. 102:virucides 9307:Biocides 9150:EARS-Net 9065:Safe sex 9017:services 8988:Lockdown 8759:measures 8661:location 8641:Syndemic 8636:Sporadic 8616:Pandemic 8611:Outbreak 8569:Epidemic 8422:Prenatal 8314:Mosquito 8198:to-human 8173:Neonatal 8166:Prenatal 8114:Zoonosis 7959:concepts 7890:Humidity 7875:Commerce 7751:Diabetes 7684:Exotoxin 7048:Ruzasvir 7018:Elbasvir 6699:Adefovir 6601:assembly 6592:Vaccinia 6469:cytosine 6173:Loviride 5015:Serenics 4680:Vaccines 4447:Fibrates 4269:Vitamins 4219:Antacids 4026:25807314 3986:PLOS ONE 3967:26473026 3916:34636311 3692:28319996 3643:26819511 3575:20466277 3518:19258250 3477:28694997 3384:21148489 3335:29588540 3295:19906671 3167:19048205 3126:22710439 3118:19513050 3076:20375034 2936:71595650 2928:18847315 2881:18978532 2838:19235659 2803:11585785 2724:J. Virol 2716:Sodeik B 2702:21818340 2662:PLOS ONE 2607:10411656 2566:19171928 2517:19048198 2466:43114821 2417:11282007 2382:14659071 2341:15140987 2311:J. Virol 2284:12883495 2243:15795296 2213:J. Virol 2194:15795246 2145:11763348 2054:10471549 1950:J. Virol 1931:21222121 1923:10325536 1848:16136207 1777:32679173 1728:35164129 1658:31050421 1525:33557246 1474:33726557 1425:11338678 1398:12799460 1324:25108173 1273:31643973 1267:. 2012. 1226:Virucide 1177:See also 1049:Zepatier 817:Assembly 811:caspases 784:, Guama 736:in vitro 728:shiitake 717:protease 522:degree. 381:receptor 311:bacteria 8954:Hygiene 8892:booster 8825:Asepsis 8564:Endemic 8559:Cluster 8143:Source 8078:Biofilm 7915:Poverty 7885:Ecology 7863:El Niño 7816:Smoking 7694:factors 7635:Biofilm 7611:Outline 7472:NITD008 7110:IDX-184 7105:GS-6620 6882:, also 6443:thymine 6414:uridine 6389:adenine 6353:guanine 6292:, also 6072:KP-1461 5618:Racivir 5388:MK-2048 4872:General 4779:muscles 4748:L03–L04 4744:disease 4696:L01–L02 4692:disease 4442:Statins 4017:4373943 3994:Bibcode 3958:4606524 3825:4530725 3748:4299677 3683:5486987 3634:4721977 3566:2871161 3468:5499642 3425:9182098 3375:3086431 3286:2842737 3035:9728000 3026:1113839 2889:3065481 2754:8289340 2693:3144912 2670:Bibcode 2643:2469420 2557:3170409 2508:7120715 2458:2834223 2292:1612244 2234:1069583 2185:1069577 1980:1850030 1839:1193547 1768:7361119 1719:8839652 1570:7120554 1516:7913928 1465:7975490 1366:Bibcode 1315:7113776 1055:Mavyret 1037:Epclusa 1031:Harvoni 798:in vivo 581:RNase H 432:" and " 396:ligands 334:protein 330:enzymes 322:Viruses 251:scholar 67:viruses 9162:CRISPR 9114:Zoning 8969:Gloves 8380:Fomite 8214:Routes 8109:Vector 7976:Fomite 7957:Basic 7920:Travel 7800:Gender 7541:WHO-EM 7457:MK-608 7427:CMX521 7245:agents 6808:WHO-EM 6694:NtRTIs 6657:NARTIs 6454:FV-100 6206:WHO-EM 6022:BIT225 6017:Abzyme 5948:(gene) 5635:NtRTIs 5530:(RTIs) 5179:  5158:  5106:other 5037:system 4789:joints 4742:immune 4549:system 4509:system 4350:system 4024:  4014:  3965:  3955:  3914:  3822:  3745:  3690:  3680:  3641:  3631:  3573:  3563:  3524:  3516:  3475:  3465:  3423:  3382:  3372:  3333:  3293:  3283:  3165:  3155:  3124:  3116:  3074:  3033:  3023:  2934:  2926:  2887:  2879:  2844:  2836:  2801:  2791:  2752:  2745:236549 2742:  2700:  2690:  2641:  2605:  2564:  2554:  2515:  2505:  2495:  2464:  2456:  2415:  2380:  2339:  2332:415795 2329:  2290:  2282:  2241:  2231:  2192:  2182:  2143:  2052:  2042:  2001:  1978:  1971:240614 1968:  1929:  1921:  1887:  1877:  1846:  1836:  1793:. 2022 1775:  1765:  1726:  1716:  1708:  1664:  1656:  1648:  1608:  1567:  1557:  1523:  1513:  1472:  1462:  1423:  1396:  1389:164704 1386:  1322:  1312:  1271:  1097:), or 1043:Vosevi 667:dengue 603:, and 492:, and 338:capsid 326:genome 253:  246:  239:  232:  224:  128:, the 9234:Other 8742:Fetus 8737:Mouth 8732:Tooth 8727:Blood 8714:Joint 8574:Curve 8444:Other 8391:wound 8389:Open 8359:Feces 8354:Water 8045:Modes 7903:Flood 7627:Agent 7508:EICAR 7241:Anti- 6888:D06BB 6884:S01AD 6645:(VII) 6508:Other 6298:D06BB 6294:S01AD 6010:Other 5993:BNAbs 5553:NRTIs 5332:gp120 5160:Drugs 4877:Local 4844:brain 4783:bones 4284:blood 4054:(PDF) 4047:(PDF) 3731:(1). 3522:S2CID 3122:S2CID 2932:S2CID 2885:S2CID 2842:S2CID 2794:89003 2462:S2CID 2288:S2CID 2045:89431 1927:S2CID 1885:S2CID 1662:S2CID 761:DRACO 748:dsRNA 342:lipid 258:JSTOR 244:books 95:treat 8998:list 8919:Non- 8709:Bone 8701:Skin 8385:Soil 8375:Burn 8337:Food 8319:Tick 7981:Host 7741:Burn 7733:Host 7068:NS5B 6999:NS5A 6886:and 6296:and 6235:DHHS 5291:CCR5 5279:gp41 4787:and 4464:skin 4146:2016 4121:2016 4062:2016 4022:PMID 3963:PMID 3912:PMID 3846:JAMA 3688:PMID 3639:PMID 3571:PMID 3514:PMID 3473:PMID 3421:PMID 3380:PMID 3331:PMID 3291:PMID 3246:2018 3217:2018 3163:PMID 3153:ISBN 3114:PMID 3083:2018 3072:PMID 3031:PMID 2948:2018 2924:PMID 2877:PMID 2834:PMID 2799:PMID 2750:PMID 2698:PMID 2639:PMID 2603:PMID 2562:PMID 2513:PMID 2493:ISBN 2454:PMID 2413:PMID 2378:PMID 2337:PMID 2280:PMID 2239:PMID 2190:PMID 2141:PMID 2095:2022 2050:PMID 1999:ISBN 1976:PMID 1919:PMID 1875:ISBN 1844:PMID 1799:2024 1773:PMID 1724:PMID 1706:ISSN 1654:PMID 1646:ISSN 1606:ISSN 1555:ISBN 1521:PMID 1470:PMID 1421:PMID 1394:PMID 1358:PNAS 1320:PMID 1269:PMID 1233:and 896:The 792:and 517:and 462:and 434:CCR5 230:news 154:AIDS 140:and 132:and 108:and 85:and 9058:PPE 8746:Eye 8407:Sex 8228:Air 7797:Age 6906:NS3 6880:J05 6561:HPV 6290:J05 5316:CD4 5235:J05 5231:HIV 5108:ATC 4846:and 4605:and 4012:PMC 4002:doi 3953:PMC 3943:doi 3904:doi 3877:doi 3850:308 3820:PMC 3810:doi 3777:doi 3743:PMC 3733:doi 3678:PMC 3670:doi 3666:166 3629:PMC 3619:doi 3561:PMC 3553:doi 3504:doi 3500:360 3463:PMC 3455:doi 3411:doi 3370:PMC 3362:doi 3358:203 3321:doi 3281:PMC 3273:doi 3269:277 3145:doi 3106:doi 3062:doi 3021:PMC 3013:doi 3009:317 3005:BMJ 2981:CDC 2916:doi 2869:doi 2826:doi 2789:PMC 2781:doi 2740:PMC 2732:doi 2688:PMC 2678:doi 2631:doi 2627:160 2593:doi 2589:262 2552:PMC 2544:doi 2503:PMC 2485:doi 2444:doi 2440:231 2405:doi 2368:doi 2327:PMC 2319:doi 2270:doi 2229:PMC 2221:doi 2180:PMC 2172:doi 2133:doi 2040:PMC 2032:doi 1966:PMC 1958:doi 1911:doi 1867:doi 1834:PMC 1826:doi 1763:PMC 1755:doi 1714:PMC 1696:doi 1638:doi 1598:doi 1565:PMC 1547:doi 1511:PMC 1501:doi 1460:PMC 1452:doi 1384:PMC 1374:doi 1362:100 1310:PMC 1300:doi 1296:110 1099:AZT 1089:), 1071:RNA 975:WHO 672:HCV 552:DNA 550:or 548:RNA 542:or 430:CD4 213:by 156:). 122:HIV 9298:: 7554:: 7319:, 6910:4A 6821:: 6565:MC 6334:TK 6219:: 5323:, 5307:, 5303:, 5225:: 4983:/ 4781:, 4631:: 4620:QI 4618:, 4614:, 4591:/ 4252:/ 4199:/ 4137:. 4112:. 4094:. 4034:^ 4020:. 4010:. 4000:. 3990:10 3988:. 3984:. 3961:. 3951:. 3937:. 3933:. 3910:. 3900:21 3898:. 3873:69 3871:. 3858:^ 3848:. 3844:. 3818:. 3806:61 3804:. 3800:. 3773:61 3771:. 3767:. 3741:. 3729:15 3727:. 3723:. 3686:. 3676:. 3664:. 3660:. 3637:. 3627:. 3615:22 3613:. 3609:. 3583:^ 3569:. 3559:. 3549:24 3547:. 3543:. 3520:. 3512:. 3498:. 3494:. 3471:. 3461:. 3449:. 3445:. 3433:^ 3419:. 3407:37 3405:. 3401:. 3378:. 3368:. 3356:. 3352:. 3329:. 3315:. 3311:. 3289:. 3279:. 3267:. 3263:. 3237:. 3225:^ 3197:^ 3183:. 3161:. 3151:. 3120:. 3112:. 3102:27 3100:. 3070:. 3058:65 3056:. 3052:. 3029:. 3019:. 3007:. 3003:. 2989:^ 2979:. 2956:^ 2930:. 2922:. 2906:. 2883:. 2875:. 2865:21 2863:. 2840:. 2832:. 2822:29 2820:. 2797:. 2787:. 2777:14 2775:. 2771:. 2748:. 2738:. 2728:68 2726:. 2722:. 2696:. 2686:. 2676:. 2664:. 2660:. 2637:. 2625:. 2601:. 2587:. 2583:. 2560:. 2550:. 2540:37 2538:. 2534:. 2511:. 2501:. 2491:. 2460:. 2452:. 2438:. 2434:. 2411:. 2401:17 2399:. 2376:. 2364:36 2362:. 2358:. 2335:. 2325:. 2315:78 2313:. 2309:. 2286:. 2278:. 2266:38 2264:. 2260:. 2237:. 2227:. 2217:79 2215:. 2211:. 2188:. 2178:. 2168:79 2166:. 2162:. 2139:. 2129:11 2127:. 2048:. 2038:. 2028:43 2026:. 2022:. 1974:. 1964:. 1954:65 1952:. 1948:. 1925:. 1917:. 1907:41 1905:. 1883:, 1873:, 1842:. 1832:. 1820:. 1816:. 1771:. 1761:. 1751:25 1749:. 1745:. 1722:. 1712:. 1704:. 1692:27 1690:. 1686:. 1674:^ 1660:. 1652:. 1644:. 1634:62 1632:. 1628:. 1604:. 1594:17 1592:. 1588:. 1563:. 1553:. 1533:^ 1519:. 1509:. 1497:26 1495:. 1491:. 1468:. 1458:. 1448:35 1446:. 1442:. 1417:56 1415:. 1392:. 1382:. 1372:. 1360:. 1356:. 1318:. 1308:. 1294:. 1290:. 788:, 738:. 607:. 599:, 513:, 496:. 488:, 124:, 112:. 7613:) 7609:( 7598:e 7591:t 7584:v 7412:) 7408:( 7397:) 7393:( 7323:) 7305:( 7300:/ 7291:) 7277:( 7272:/ 7229:: 6908:/ 6890:) 6865:e 6858:t 6851:v 6783:/ 6696:: 6692:/ 6659:: 6655:/ 6603:: 6575:/ 6563:/ 6543:) 6539:( 6476:) 6472:( 6436:) 6430:) 6426:( 6417:( 6396:) 6392:( 6382:) 6378:/ 6369:/ 6360:/ 6356:( 6300:) 6275:e 6268:t 6261:v 6233:° 5821:° 5815:° 5809:° 5798:° 5782:° 5766:° 5663:) 5659:( 5637:: 5633:/ 5555:: 5551:/ 5503:° 5497:° 5434:) 5430:( 5339:) 5335:( 5327:) 5319:( 5311:) 5294:( 5286:) 5282:( 5270:) 5266:( 5237:) 5215:e 5208:t 5201:v 5114:) 5112:V 5110:( 5085:) 5083:S 5081:( 5067:1 5065:H 5043:) 5041:R 5039:( 4855:) 4853:N 4851:( 4795:) 4793:M 4791:( 4785:, 4750:) 4746:( 4698:) 4694:( 4639:) 4635:( 4622:) 4616:P 4612:J 4610:( 4555:) 4553:H 4551:( 4515:) 4513:G 4511:( 4470:) 4468:D 4466:( 4356:) 4354:C 4352:( 4292:) 4290:B 4226:2 4224:H 4207:) 4205:A 4203:( 4179:e 4172:t 4165:v 4148:. 4123:. 4098:. 4079:. 4064:. 4028:. 4004:: 3996:: 3969:. 3945:: 3939:4 3918:. 3906:: 3883:. 3879:: 3828:. 3812:: 3785:. 3779:: 3751:. 3735:: 3694:. 3672:: 3645:. 3621:: 3577:. 3555:: 3528:. 3506:: 3479:. 3457:: 3451:2 3427:. 3413:: 3386:. 3364:: 3337:. 3323:: 3317:3 3297:. 3275:: 3248:. 3219:. 3169:. 3147:: 3128:. 3108:: 3085:. 3064:: 3037:. 3015:: 2950:. 2918:: 2912:8 2891:. 2871:: 2848:. 2828:: 2805:. 2783:: 2756:. 2734:: 2704:. 2680:: 2672:: 2666:6 2645:. 2633:: 2609:. 2595:: 2568:. 2546:: 2519:. 2487:: 2468:. 2446:: 2419:. 2407:: 2384:. 2370:: 2343:. 2321:: 2294:. 2272:: 2245:. 2223:: 2196:. 2174:: 2147:. 2135:: 2112:. 2097:. 2056:. 2034:: 2007:. 1982:. 1960:: 1933:. 1913:: 1869:: 1850:. 1828:: 1822:2 1801:. 1779:. 1757:: 1730:. 1698:: 1668:. 1640:: 1612:. 1600:: 1573:. 1549:: 1527:. 1503:: 1476:. 1454:: 1427:. 1400:. 1376:: 1368:: 1326:. 1302:: 1275:. 764:( 663:) 280:) 274:( 269:) 265:( 255:· 248:· 241:· 234:· 207:. 142:B 134:C 41:. 34:. 20:)

Index

Anti-viral therapy
Antiviral (disambiguation)
Antiviral Therapy (journal)

medication
viral infections
viruses
broad-spectrum antiviral
antimicrobials
antibiotic
antifungal
antiparasitic
monoclonal antibodies
treat
infections
virucides
eucalyptus
Australian tea trees
HIV
herpes viruses
hepatitis B
C
influenza A
B
AIDS
herpes viruses
trial-and-error
side effects
genetic sequences

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑